Please wait

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q


x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2014

or
 
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from______ to ______

 Commission File Number: 001-36372
SQUARE 1 FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
 
Delaware                 
 
 
 
20-1872698           
(State or other jurisdiction of
incorporation or organization)
 
 
 
(IRS Employer
Identification Number)
 
 
 
 
 
406 Blackwell Street, Suite 240
Durham, North Carolina
 
 
 
27701
(Address of principal executive offices)
 
 
 
(Zip Code)
 
 
 
 
 
(866) 355-0468
(Registrant’s telephone number, including area code)
 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one)
Large accelerated filer
 
¨
  
Accelerated filer
 
¨
Non-accelerated filer
 
x  (Do not check if a smaller reporting company)
  
Smaller reporting company
 
¨
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨    No  x
At October 31, 2014, 28,708,925 shares of the registrant’s common stock ($0.01 par value) were outstanding.



TABLE OF CONTENTS
 
 
 
 
 
 
Page
 
 
 
PART I.
FINANCIAL INFORMATION
 
 
 
 
ITEM 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 2.
 
 
 
ITEM 3.
 
 
 
ITEM 4.
 
 
 
 
 
 
PART II.
OTHER INFORMATION
 
 
 
 
ITEM 1.
 
 
 
ITEM 1A.
 
 
 
ITEM 2.
 
 
 
ITEM 3.
 
 
 
ITEM 5.
 
 
 
ITEM 6.
 
 
 




PART I - FINANCIAL INFORMATION
ITEM 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Square 1 Financial, Inc.
Interim Consolidated Balance Sheets
(in thousands, except share and per share data)
September 30, 2014
 
December 31, 2013
Assets
(Unaudited)
 

Cash and cash equivalents
$
185,606

 
$
105,730

Investment in time deposits
1,250

 
1,250

Investment securities—available for sale, at fair value
1,186,887

 
924,229

Investment securities—held to maturity, at amortized cost
278,121

 
154,255

Loans, net of unearned income of $7.3 million and $4.5 million
1,271,457

 
1,082,536

Less allowance for loan losses
(22,816
)
 
(18,379
)
Net loans
1,248,641

 
1,064,157

Premises and equipment, net
3,723

 
3,061

Deferred income tax assets, net
10,142

 
15,620

Bank owned life insurance
50,278

 
31,706

Intangible assets
1,770

 
2,065

Other receivables
3,619

 
2,592

Warrant valuation
4,089

 
5,105

Prepaid expenses
1,690

 
1,309

Accrued interest receivable and other assets
12,370

 
15,348

Total assets
$
2,988,186

 
$
2,326,427

Liabilities and Shareholders’ Equity

 

Deposits:

 

Demand, noninterest-bearing
$
1,712,674

 
$
1,380,024

Demand, interest-bearing
164,859

 
103,638

Money market deposit accounts
774,405

 
596,247

Time deposits
16,507

 
26,818

Total deposits
2,668,445

 
2,106,727

Borrowings and repurchase agreements

 
12,737

Junior subordinated debt

 
6,207

Accrued interest payable and other liabilities
25,539

 
11,607

Total liabilities
$
2,693,984

 
$
2,137,278

Commitments and contingencies (Notes 11 and 16)

 

Shareholders’ equity:

 

Convertible preferred stock, $.01 par value; 10,000,000 shares authorized, 0 shares and 5,000 shares issued and outstanding, respectively

 

Common stock, $.01 par value; 70,000,000 and 45,000,000 shares authorized, 28,700,825 shares and 23,611,746 shares issued and outstanding, respectively
287

 
236

Additional paid in capital
251,841

 
183,716

Accumulated other comprehensive income (loss)
8,193

 
(4,096
)
Retained earnings
33,881

 
9,293

Total shareholders’ equity
294,202

 
189,149

Total liabilities and shareholders’ equity
$
2,988,186

 
$
2,326,427

The accompanying notes are an integral part of these consolidated financial statements.

3


Square 1 Financial, Inc.
Interim Consolidated Statements of Operations (Unaudited)
(in thousands, except per share data)
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
 
2014
 
2013
 
2014
 
2013
Interest income:
 

 

 
 
 
 
Loans including fees on loans
 
$
19,326

 
$
14,949

 
$
53,448

 
$
41,575

Investment securities
 
7,528

 
4,993

 
21,079

 
13,266

Federal funds and other short-term investments
 
104

 
78

 
305

 
233

Total interest income
 
26,958

 
20,020

 
74,832

 
55,074

Interest expense:
 

 

 
 
 
 
Deposits
 
150

 
182

 
423

 
476

Borrowings and repurchase agreements
 

 
6

 
4

 
30

Junior subordinated debt
 

 
158

 
215

 
475

Total interest expense
 
150

 
346

 
642

 
981

Net interest income
 
26,808

 
19,674

 
74,190

 
54,093

Provision for loan losses
 
2,500

 
2,850

 
8,614

 
9,340

Net interest income after provision for loan losses
 
24,308

 
16,824

 
65,576

 
44,753

Noninterest income:
 

 

 
 
 
 
Service charges and fees
 
1,150

 
1,069

 
3,345

 
3,020

Foreign exchange fees
 
1,792

 
1,270

 
4,795

 
3,635

Credit card and merchant income
 
914

 
605

 
2,314

 
1,787

Investment impairment
 

 
(782
)
 
(43
)
 
(1,525
)
Net (loss) gain on securities
 
(235
)
 
847

 
(188
)
 
1,696

Letter of credit fees
 
293

 
271

 
1,104

 
785

Warrant income
 
721

 
899

 
2,937

 
3,263

Gain on sale of loans
 
248

 
444

 
750

 
1,665

Bank owned life insurance
 
330

 
298

 
936

 
771

Other
 
319

 
1,808

 
3,094

 
3,243

Total noninterest income
 
5,532

 
6,729

 
19,044

 
18,340

Noninterest expense:
 

 

 
 
 
 
Personnel
 
10,790

 
8,639

 
32,148

 
26,128

Occupancy
 
713

 
691

 
2,227

 
2,082

Data processing
 
1,090

 
897

 
2,830

 
2,229

Furniture and equipment
 
769

 
589

 
2,131

 
1,850

Advertising and promotions
 
223

 
267

 
840

 
891

Professional fees
 
976

 
876

 
2,363

 
2,280

Telecommunications
 
246

 
283

 
791

 
866

Travel
 
259

 
211

 
717

 
762

FDIC assessment
 
393

 
349

 
1,145

 
949

Other
 
1,376

 
857

 
3,826

 
2,768

Total noninterest expense
 
16,835

 
13,659

 
49,018

 
40,805

Income before income tax expense
 
13,005

 
9,894

 
35,602

 
22,288

Income tax expense
 
4,253

 
2,926

 
10,951

 
6,845

Net income
 
8,752

 
6,968

 
24,651

 
15,443

Dividends on preferred stock
 

 
62

 
63

 
188

Net income available to common shareholders
 
$
8,752

 
$
6,906

 
$
24,588

 
$
15,255

Earnings per share—basic
 
$
0.31

 
$
0.29

 
$
0.91

 
$
0.65

Earnings per share—diluted
 
$
0.29

 
$
0.29

 
$
0.87

 
$
0.64

The accompanying notes are an integral part of these consolidated financial statements.

4


Square 1 Financial, Inc.
Interim Consolidated Statements of Comprehensive Income (Unaudited)
 
(in thousands)
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
 
2014
 
2013
 
2014
 
2013
Net income
 
$
8,752

 
$
6,968

 
$
24,651

 
$
15,443

Other comprehensive income, net of tax:
 
 
 
 
 
 
 
 
Unrealized gains on securities:
 
 
 
 
 
 
 
 
Unrealized holding gains (losses) arising during period
 
740

 
(1,891
)
 
12,186

 
(9,312
)
Less: reclassification adjustment for losses (gains) included in net income
 
145

 
(887
)
 
103

 
(1,332
)
Other comprehensive income (loss)
 
885

 
(2,778
)
 
12,289

 
(10,644
)
Comprehensive income
 
9,637

 
4,190

 
36,940

 
4,799

Dividends on preferred stock
 

 
62

 
63

 
188

Comprehensive income available to common shareholders
 
$
9,637

 
$
4,128

 
$
36,877

 
$
4,611

The accompanying notes are an integral part of these consolidated financial statements.

5


Square 1 Financial, Inc.
Interim Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)
 
(dollars in thousands)
Preferred Stock
 
Common Stock
 
Additional
Paid in
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Retained
(Deficit) Earnings
 
Total

Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Balance at December 31, 2012
5,000

 
$

 
23,491,697

 
$
235

 
$
182,135

 
$
7,195

 
$
(12,839
)
 
$
176,726

Issuance of common stock, net issuance costs of $1 thousand

 

 
9,566

 

 
29

 

 

 
29

Stock-based compensation

 

 

 

 
1,047

 

 

 
1,047

Dividends on preferred stock

 

 

 

 

 

 
(188
)
 
(188
)
Net income

 

 

 

 

 

 
15,443

 
15,443

Unrealized loss on securities net of tax of $6.3 million

 

 

 

 

 
(10,644
)
 

 
(10,644
)
Balance at September 30, 2013
5,000

 
$

 
23,501,263

 
$
235

 
$
183,211

 
$
(3,449
)
 
$
2,416

 
$
182,413

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2013
5,000

 
$

 
23,611,746

 
$
236

 
$
183,716

 
$
(4,096
)
 
$
9,293

 
$
189,149

Issuance of common stock, net issuance costs of $2.3 million

 

 
3,847,509

 
39

 
60,008

 

 

 
60,047

Stock-based compensation

 

 

 

 
2,098

 

 

 
2,098

Conversion of preferred stock
(5,000
)
 

 
500,070

 
5

 
(4
)
 

 

 
1

Conversion of trust preferred securities

 

 
741,500

 
7

 
6,023

 

 

 
6,030

Dividends on preferred stock

 

 

 

 

 

 
(63
)
 
(63
)
Net income

 

 

 

 

 

 
24,651

 
24,651

Unrealized gain on securities net of tax of $7.5 million

 

 

 

 

 
12,289

 

 
12,289

Balance at September 30, 2014

 
$

 
28,700,825

 
$
287

 
$
251,841

 
$
8,193

 
$
33,881

 
$
294,202

The accompanying notes are an integral part of these consolidated financial statements.

6


Square 1 Financial, Inc.
Interim Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Nine Months Ended 
 September 30,
 
2014
 
2013
Net income
$
24,651

 
$
15,443

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
720

 
845

Amortization on investment securities, net
13,366

 
12,190

Provision for loan losses
8,614

 
9,340

Stock-based compensation
2,390

 
1,059

Loss (gain) on sale of securities available for sale
188

 
(1,696
)
Investment impairment
43

 
1,525

Deferred income tax provision
(2,036
)
 
(1,566
)
Earnings on bank owned life insurance
(936
)
 
(771
)
Changes in assets and liabilities:
 
 
 
Accrued interest receivable and other assets
2,880

 
(4,169
)
Accrued interest payable and other liabilities
13,931

 
(1,183
)
Net cash provided by operating activities
63,811

 
31,017

Cash flows from investing activities:
 
 
 
Purchase of securities available for sale
(413,659
)
 
(351,909
)
Purchase of securities held to maturity
(90,635
)
 
(56,135
)
Proceeds from calls/maturities of securities available for sale
118,172

 
117,891

Proceeds from sales of securities available for sale
3,419

 
77,902

Proceeds from paydowns of securities held to maturity
2,387

 
2,047

Net increase in loans
(193,097
)
 
(160,848
)
Purchase of bank owned life insurance
(17,635
)
 
(10,000
)
Purchases of premises and equipment
(1,383
)
 
(369
)
Net cash used in investing activities
(592,431
)
 
(381,421
)
Cash flows from financing activities:
 
 
 
Net increase in deposits
561,718

 
345,061

Net (decrease) increase in repurchase agreements
(12,737
)
 
25,605

Decrease in FHLB borrowings

 
(15,000
)
(Decrease) increase in subordinated debt
(6,207
)
 
1

Preferred dividends paid
(63
)
 
(188
)
Proceeds from issuance of common stock, net of issuance costs
65,004

 
(1
)
Proceeds from issuance of shares under stock-based compensation plan
781

 
18

Net cash provided by financing activities
608,496

 
355,496

Net change in cash and cash equivalents
79,876

 
5,092

Cash and cash equivalents at beginning of year
105,730

 
48,971

Cash and cash equivalents at end of year
$
185,606

 
$
54,063

Supplemental statement of cash flow disclosures
 
 
 
Interest paid
$
642

 
$
981

Income taxes paid
$
13,470

 
$
7,815

The accompanying notes are an integral part of these consolidated financial statements.

7


Notes to the Interim Consolidated Financial Statements (Unaudited)

1.
ORGANIZATION AND BASIS OF PRESENTATION
Organization and Nature of Operations
Square 1 Financial, Inc. (the “Company”) is a bank holding company incorporated under the laws of Delaware on October 6, 2004. The Company’s primary function is to serve as the holding company for its wholly-owned subsidiary, Square 1 Bank. Square 1 Bank (the “Bank”) was incorporated under the laws of North Carolina on July 11, 2005 and commenced banking operations on August 8, 2005. The Bank is not a member of the Federal Reserve System. The Bank provides a full range of commercial banking services primarily to companies that have received institutional investment, typically from venture capital and private equity sources. The Bank’s primary source of revenue is interest earned from loans to customers and from invested cash and securities and non-interest income derived from various fees. During 2007, the Company formed Square 1 Ventures, LLC (a Delaware limited liability company); a wholly-owned subsidiary established to sponsor a fund of funds. Square 1 Ventures, LLC is consolidated into the Company’s financial statements. In 2013, the Bank formed Square 1 Asset Management, a wholly owned subsidiary of the Bank and SEC-registered investment adviser, to provide an investment alternative for clients. On March 31, 2014, the Company closed on its initial public offering ("IPO").
The Bank operates one branch in Durham, NC and loan production offices in Menlo Park, San Francisco, San Diego, Los Angeles, Orange County and Campbell, CA; and Austin, New York, Denver, Boston, Seattle and the District of Columbia area. The Company’s corporate headquarters are located in Durham, NC.
In September 2008, Square 1 Financial Capital Trust I (the “Trust”), a Delaware trust, was formed by the Company, as Sponsor, in order to facilitate the issuance of convertible trust preferred securities. The Trust invested the total proceeds from the sales of the convertible trust preferred securities in convertible junior subordinated deferrable interest debentures issued by the Company. The assets of the trust were not assets of the Company and were not consolidated into the Company’s consolidated financial statements. The subordinated debentures issued by the Company to the Trust were included in borrowings, and the Company’s equity interests in the Trust were included in other assets at December 31, 2013. The Company notified all holders of trust preferred securities of its intent to redeem such securities as of June 30, 2014 and all outstanding trust preferred securities were converted by the holders into shares of Company common stock prior to that date (see Note 8).
In 2013, the Bank acquired the business operations and key employees of Sand Hill Finance LLC, a factoring company located in California, as part of the Bank's strategy to continue to grow its asset-based lending portfolio. Square 1 Bank acquired approximately $11.9 million of factoring loans from Sand Hill Finance LLC and certain other assets for a total purchase price of approximately $12.4 million, which included the repayment of $7.2 million in debt. Additionally, the Bank assumed obligations under the real estate lease for the company’s primary place of business and hired the company’s seven employees. The Bank has integrated the factoring product into its existing suite of asset-based lending products.
Basis of Presentation
These unaudited interim consolidated financial statements have been prepared on a consistent basis with the accounting policies described in the notes to the audited financial statements for the fiscal year ended December 31, 2013 included in the Company's Registration Statement on Form S-1 (File No. 333-193197), which was initially filed with the Securities and Exchange Commission ("SEC") on January 6, 2014, subsequently amended thereafter and declared effective by the SEC on March 26, 2014 (the "Registration Statement"). These unaudited interim consolidated financial statements have also been prepared in accordance with the instructions for Form 10-Q pursuant to the rules and regulations of the SEC, and as such certain footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted. Because the accompanying interim financial statements do not include all of the information and footnotes required by GAAP for annual financial statements, they should be read in conjunction with the audited financial statements for the fiscal year ended December 31, 2013 and notes thereto included in the Registration Statement. Certain prior year amounts have been reclassified to conform to current year presentation.
The amounts included in these financial statements are unaudited but, in the opinion of management, reflect all adjustments necessary to fairly present the Company’s financial position and results of operations for the interim periods. Unless otherwise noted, all adjustments are normal and recurring in nature. In preparing financial statements that conform to GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities, the reported amounts of revenues and expenses and the disclosure of contingent assets and liabilities at the date of the financial

8


statements. Actual results could differ from those estimates. The results of operations for interim periods are not necessarily indicative of amounts expected for the entire year or future periods.
Principles of Consolidation
The consolidated financial statements include the financial statements of Square 1 Financial and its consolidated subsidiaries and other entities in which it has a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. In addition, the Company evaluates its relationships with other entities to identify whether they are variable interest entities ("VIEs") and to assess whether it is the primary beneficiary of such entities. If the determination was made that the Company is the primary beneficiary, then that entity would be included in the consolidated financial statements. If an entity is not a VIE, the Company also evaluates arrangements in which there is a general partner or managing member to determine whether consolidation is appropriate.
Square 1 Venture 1, L.P.-The Company owns approximately a 2% partnership interest in Square 1 Venture 1, L.P., which was formed for the primary purpose of sponsoring a fund of funds. The Company has determined that Square 1 Venture 1, L.P. is not a VIE for all periods presented; accordingly, Square 1 Venture 1, L.P. is not consolidated with the Company. The Company accounts for the investment in Square 1 Venture 1, L.P. using the equity method of accounting. For the three and nine months ended September 30, 2014, gains of $0.1 million and $0.8 million, respectively, were recognized. For the three and nine months ended September 30, 2013, gains of $0.2 million were recognized. The fair value of the investment at September 30, 2014 and December 31, 2013, was $1.8 million and $1.0 million, respectively, and is included in other assets on the balance sheet.
On April 1, 2014, Square 1 Ventures, LLC transferred the contract for the management of Square 1 Venture 1, L.P. to Industry Ventures, a fund-of-funds manager in San Francisco, CA. In connection with this transfer, we recorded a gain of $0.5 million. We do not expect the impact of the sale of the management contract to have an ongoing material impact to our results of operations or financial condition.
Use of Estimates in the Preparation of Financial Statements
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The more significant estimates that are particularly susceptible to significant change relate to the determination of the allowance for loan losses, the valuation of investment securities, recognition and measurement of income tax assets and liabilities and the valuation of equity warrant assets and foreclosed assets.
Cash and Cash Equivalents
Cash and cash equivalents include noninterest-earning and interest-earning deposits at other institutions, federal funds sold and other short term investments. Generally, federal funds are purchased and sold for one-day periods. At times, the Bank places deposits with high credit-quality financial institutions in amounts which may be in excess of federally insured limits. The Bank is required to maintain reserve and clearing balances with the Federal Reserve Bank. Accordingly, the Bank has amounts restricted for this purpose of $15.5 million and $12.0 million in the consolidated balance sheet at September 30, 2014 and December 31, 2013, respectively.
2.
NEW ACCOUNTING STANDARDS
In August 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. ASU 2014-15 requires that in connection with preparing financial statements for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued (or at the date that the financial statements are available to be issued when applicable). ASU 2014-15 also provides principles for considering the mitigating effect of management’s plans, requires certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans and requires an express statement and other disclosures when substantial doubt is not alleviated. For the Company, ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual periods and

9


interim periods thereafter. Early adoption is permitted. The Company does not expect adoption of ASU 2014-15 to have a material effect on its consolidated results of operations, financial position or disclosures.
In June 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures. ASU 2014-11 requires that repurchase-to-maturity transactions be accounted for as secured borrowings consistent with the accounting for other repurchase agreements. In addition, the amendments require separate accounting for a transfer of a financial asset executed contemporaneously with a repurchase agreement with the same counterparty (a repurchase financing), which will result in secured borrowing accounting for the repurchase agreement. Additionally, the new guidance requires expanded disclosures about transfers accounted for as sales in transactions that are economically similar to repurchase agreements, in which the transferor retains substantially all of the exposure to the economic return on the transferred financial asset throughout the term of the transaction and about the types of collateral pledged in repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions and the tenor of those transactions. For the Company, ASU 2014-11 is effective for the first interim or annual period beginning after December 15, 2014. Early adoption is not permitted for public entities. The Company does not expect adoption of this ASU to have a material effect on its consolidated results of operations or financial position.
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The amendments in ASU 2014-09 create Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, and supersede the revenue recognition requirements in ASC Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance. In addition, the amendments create new ASC Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers. In summary, the core principle of ASC Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance in ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. Exclusions include lease contracts; insurance contracts; financial instruments and other contractual rights and obligations, such as receivables, investments, liabilities, debt, derivatives, and transfers and servicing; and guarantees other than product and service warranties. In addition, the existing requirements for the recognition of a gain or loss on the transfer of nonfinancial assets that are not in a contract with a customer (for example, assets within the scope of ASC Topic 360, Property, Plant, and Equipment, and intangible assets within the scope of ASC Topic 350, Intangibles-Goodwill and Other) are amended to be consistent with the guidance on recognition and measurement (including the constraint on revenue) in ASU 2014-09. An entity can apply this standard retrospectively to each prior reporting period presented (full retrospective method) or retrospectively with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings (simplified transition method). For the Company, the amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted for public entities. The Company is currently assessing the impacts of adopting ASU 2014-09.
In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. The amendments in the ASU change the criteria for reporting discontinued operations. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization’s operations and financial results. Additionally, the new guidance requires expanded disclosures about the assets, liabilities, income, and expenses of discontinued operations and requires disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify for discontinued operations reporting. For the Company, ASU No. 2014-08 would be applied prospectively to disposals or classifications as held for sale for annual financial statements with fiscal years beginning on or after December 15, 2014. Early adoption is permitted. The Company does not expect adoption of this ASU to have a material effect on its consolidated results of operations or financial position.
The FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting reclassifications out of accumulated other comprehensive income (OCI) by requiring entities to present in one place information about significant amounts reclassified and, in some cases, to provide cross-references to related footnote disclosures. The amendments do not change the current requirements for reporting net income or OCI in the financial statements, nor do they require new information to be disclosed. The amendments require prospective application and were effective for public entities in reporting periods beginning after December 15, 2012. For nonpublic companies, this revised guidance was effective on a prospective basis for interim and annual periods beginning January 1, 2014. Other than additional disclosures or a change in the presentation on the statement of comprehensive income, this revised guidance did not impact the Company's consolidated results of operations or financial position.

10


In June 2013, the FASB issued ASU 2013-08, Financial Services—Investment Companies (ASC Topic 946): Amendments to the Scope, Measurement and Disclosure Requirement. This ASU modifies the guidance in ASC 946 for determining whether an entity is an investment company, as well as the measurement and disclosure requirements for investment companies. The ASU does not change current accounting where a noninvestment company parent retains the specialized accounting applied by an investment company subsidiary in consolidation. ASU 2013-08 has been applied prospectively for all periods beginning after December 15, 2013. This ASU did not have a material effect on the Company's results of operations or financial position.
3.
INVESTMENT SECURITIES
Investments in securities are classified into three categories and accounted for as follows:
Securities Held to Maturity—Debt securities that the Company has the positive intent and ability to hold to maturity are classified as held to maturity and reported at amortized cost; or
Trading Securities—Debt and equity securities that are bought and held principally for the purpose of selling in the near term are classified as trading securities and reported at fair value, with unrealized gains and losses included in earnings; or
Securities Available for Sale—Debt and equity securities not classified as either held to maturity securities or trading securities are classified as available for sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported as other comprehensive income, a separate component of shareholders’ equity.
The Company intends to hold its securities classified as available for sale securities for an indefinite period of time but may sell them prior to maturity. All other securities, which the Company has the positive intent and ability to hold to maturity, are classified as held to maturity securities. The initial classification of securities is determined at the date of purchase. Gains and losses on sales of securities, computed based on specific identification of the adjusted cost of each security, are included in noninterest income at the time of the sales. The Company's investments include agency direct obligations, Small Business Administration ("SBA") pools, agency and non-agency mortgage backed securities ("MBS"), corporate securities, municipal bonds, and asset backed securities ("ABS"). Equity securities include securities obtained from the exercise of equity warrants and required to be held until the expiration of their respective lock-up periods, which expire within one year. The Company intends to monetize these securities upon removal of all sale restrictions (see Note 14).

11


Investment securities at September 30, 2014 and December 31, 2013, are summarized as follows:
(in thousands)
 
September 30, 2014
 
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Available for sale securities:
 
 
 
 
 
 
 
 
U.S. treasuries
 
$
19,679

 
$

 
$
(17
)
 
$
19,662

Agency direct obligations
 
34,534

 
113

 

 
34,647

SBA pools
 
143,110

 
1,973

 
(42
)
 
145,041

Agency MBS
 
577,389

 
7,747

 
(1,098
)
 
584,038

Municipal bonds
 
96,402

 
1,794

 
(70
)
 
98,126

Corporates
 
116,840

 
4,217

 
(32
)
 
121,025

Non-agency MBS
 
132,909

 
1,278

 
(1,300
)
 
132,887

Other ABS
 
49,574

 
90

 
(656
)
 
49,008

Equity securities
 
2,764

 
23

 
(334
)
 
2,453

Total
 
$
1,173,201

 
$
17,235

 
$
(3,549
)
 
$
1,186,887

Held to maturity securities:
 
 
 
 
 
 
 
 
Agency mortgaged-backed
 
$
60,663

 
$
800

 
$
(264
)
 
$
61,199

Municipal bonds
 
165,531

 
7,273

 
(606
)
 
172,198

Corporates
 
51,927

 
10

 
(2,177
)
 
49,760

Total
 
$
278,121

 
$
8,083

 
$
(3,047
)
 
$
283,157

(in thousands)
 
December 31, 2013
 
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Available for sale securities:
 
 
 
 
 
 
 
 
Agency direct obligations
 
$
34,853

 
$
208

 
$

 
$
35,061

SBA pools
 
127,309

 
1,958

 
(56
)
 
129,211

Agency mortgaged-backed
 
445,855

 
4,395

 
(2,400
)
 
447,850

Municipal bonds
 
97,532

 

 
(5,503
)
 
92,029

Corporates
 
148,288

 
1,173

 
(3,644
)
 
145,817

Non-agency mortgage-backed securities
 
54,134

 
371

 
(2,335
)
 
52,170

Other asset-backed securities
 
22,787

 
112

 
(808
)
 
22,091

Total
 
$
930,758

 
$
8,217

 
$
(14,746
)
 
$
924,229

Held to maturity securities:
 
 
 
 
 
 
 
 
Agency mortgaged-backed
 
$
18,666

 
$
188

 
$
(608
)
 
$
18,246

Municipal bonds
 
127,339

 
426

 
(5,756
)
 
122,009

Corporates
 
8,250

 

 
(1,951
)
 
6,299

Total
 
$
154,255

 
$
614

 
$
(8,315
)
 
$
146,554

Investment securities with a fair value of $297.0 million and $343.7 million at September 30, 2014 and December 31, 2013, respectively, were pledged to secure customer repurchase agreements and to secure prospective borrowing capacities at our correspondent banks, the Federal Reserve Bank, and the Federal Home Loan Bank of Atlanta.

12


The following tables show the gross unrealized losses and fair value of the Company’s investments with unrealized losses that are not deemed to be other-than-temporarily impaired. Investment securities contained in the table are aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at September 30, 2014 and December 31, 2013:
(in thousands)
 
September 30, 2014
 
 
Less Than 12 Months
 
12 Months or Greater
 
Total
 
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
Available for sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasuries
 
$
19,662

 
$
(17
)
 
$

 
$

 
$
19,662

 
$
(17
)
SBA Pools
 
4,906

 
(34
)
 
4,440

 
(8
)
 
9,346

 
(42
)
Agency MBS
 
115,807

 
(801
)
 
24,197

 
(297
)
 
140,004

 
(1,098
)
Municipal Bonds
 
3,780

 
(7
)
 
6,390

 
(63
)
 
10,170

 
(70
)
Corporates
 
5,013

 
(32
)
 

 

 
5,013

 
(32
)
Non-Agency MBS
 
57,578

 
(476
)
 
18,888

 
(824
)
 
76,466

 
(1,300
)
Other ABS
 
5,306

 
(8
)
 
4,819

 
(648
)
 
10,125

 
(656
)
Equity securities
 
2,218

 
(334
)
 

 

 
2,218

 
(334
)
Total
 
$
214,270

 
$
(1,709
)
 
$
58,734

 
$
(1,840
)
 
$
273,004

 
$
(3,549
)
Held to maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency MBS
 
$
4,970

 
$
(26
)
 
$
5,971

 
$
(238
)
 
$
10,941

 
$
(264
)
Municipal Bonds
 
11,022

 
(80
)
 
22,345

 
(526
)
 
33,367

 
(606
)
Corporates
 
39,120

 
(658
)
 
6,750

 
(1,519
)
 
45,870

 
(2,177
)
Total
 
$
55,112

 
$
(764
)
 
$
35,066

 
$
(2,283
)
 
$
90,178

 
$
(3,047
)
(in thousands)
 
December 31, 2013
 
 
Less Than 12 Months
 
12 Months or Greater
 
Total
 
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
Available for sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
SBA Pools
 
$
13,724

 
$
(56
)
 
$

 
$

 
$
13,724

 
$
(56
)
Agency MBS
 
126,563

 
(1,801
)
 
24,288

 
(599
)
 
150,851

 
(2,400
)
Municipal Bonds
 
92,029

 
(5,503
)
 

 

 
92,029

 
(5,503
)
Corporates
 
72,092

 
(3,644
)
 

 

 
72,092

 
(3,644
)
Non-Agency MBS
 
22,422

 
(410
)
 
14,138

 
(1,925
)
 
36,560

 
(2,335
)
Other ABS
 

 

 
4,852

 
(808
)
 
4,852

 
(808
)
Total
 
$
326,830

 
$
(11,414
)
 
$
43,278

 
$
(3,332
)
 
$
370,108

 
$
(14,746
)
Held to maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
Agency MBS
 
$
13,575

 
$
(608
)
 
$

 
$

 
$
13,575

 
$
(608
)
Municipal Bonds
 
77,344

 
(3,313
)
 
16,368

 
(2,443
)
 
93,712

 
(5,756
)
Corporates
 

 

 
6,299

 
(1,951
)
 
6,299

 
(1,951
)
Total
 
$
90,919

 
$
(3,921
)
 
$
22,667

 
$
(4,394
)
 
$
113,586

 
$
(8,315
)
At September 30, 2014, there were a total of 74 available for sale securities that were in an unrealized loss position, of which 26 investments had fair values less than their amortized cost for a period of time greater than 12 months. At December 31, 2013, there were a total of 104 available for sale securities that were in an unrealized loss position, of which 25 investments had fair values less than their amortized cost for a period of time greater than 12 months. At September 30, 2014, the fair value of equity securities included $1.3 million in equity securities obtained from the exercise of equity warrants, which the Company intends to monetize upon removal of all sale restrictions, and $1.1 million in other equity securities.

13


The Company performs extensive ongoing evaluations of the investment portfolio at the individual bond level, including market valuations and impairment analyses. The Company had no recorded impairment for the three months ended September 30, 2014 and $0.8 million of impairment on certain mortgage-related securities for the three months ended September 30, 2013. The Company had recorded impairment of $43 thousand and $1.5 million of impairment on certain mortgage-related securities for the nine months ended September 30, 2014 and 2013, respectively. The Company had deemed these securities permanently impaired and unlikely to receive full principal, even if the investments were held to maturity. The Company believes the remainder of the investment portfolio, based on the evaluation performed, will be paid in full and that any temporary impairment will be fully recoverable prior to or at maturity. The Company has the ability and intent to hold the investment securities for a reasonable period of time sufficient for a forecasted recovery of fair value or until maturity.
The amortized cost of debt securities at September 30, 2014, by contractual maturity, is shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
(in thousands)
 
September 30, 2014
 
 
Total
Amortized
Cost
 
Less than
One Year
Amortized
Cost
 
After One
Year to
Five Years
Amortized
Cost
 
After Five
Years to
Ten Years
Amortized
Cost
 
After Ten
Years
Amortized
Cost
Available for sale securities:
 
 
 
 
 
 
 
 
 
 
Contractual maturity
 
 
 
 
 
 
 
 
 
 
U.S. Treasuries
 
$
19,679

 
$

 
$
19,679

 
$

 
$

Agency Direct Obligations
 
34,534

 
3,890

 
30,644

 

 

SBA Pools
 
143,110

 

 
5,200

 
60,428

 
77,482

Agency MBS
 
577,389

 

 
1,856

 
35,356

 
540,177

Municipal Bonds
 
96,402

 

 

 
12,016

 
84,386

Corporates
 
116,840

 

 
55,687

 
12,950

 
48,203

Non-Agency MBS
 
132,909

 

 
1,495

 
15,316

 
116,098

Other ABS
 
49,574

 
12,999

 
15,831

 
15,277

 
5,467

Equity securities
 
2,764

 

 

 

 
2,764

Total
 
$
1,173,201

 
$
16,889

 
$
130,392

 
$
151,343

 
$
874,577

Held to maturity securities:
 
 
 
 
 
 
 
 
 
 
Contractual maturity
 
 
 
 
 
 
 
 
 
 
Agency MBS
 
$
60,663

 
$

 
$

 
$

 
$
60,663

Municipal Bonds
 
165,531

 

 

 
7,460

 
158,071

Corporates
 
51,927

 

 

 

 
51,927

Total
 
$
278,121

 
$

 
$

 
$
7,460

 
$
270,661


14


4.
LOANS AND ALLOWANCE FOR LOAN LOSSES
Loans
The composition of loans, net of unearned income, broken out by portfolio segment at September 30, 2014 and December 31, 2013, are as follows:
(in thousands)
 
September 30, 2014
 
December 31, 2013
Commercial loans:
 
 
 
 
Technology
 
$
634,908

 
$
543,788

Life sciences
 
240,375

 
224,069

Asset-based loans
 
152,282

 
111,251

Venture capital/private equity
 
159,349

 
143,468

SBA and USDA
 
33,245

 
23,719

Other
 
5,468

 
1,424

Total commercial loans
 
1,225,627

 
1,047,719

Real estate loans:
 
 
 
 
SBA and USDA
 
31,532

 
27,504

Total real estate loans
 
31,532

 
27,504

Construction loans:
 
 
 
 
SBA and USDA
 
2,290

 
287

Total construction loans
 
2,290

 
287

Credit cards
 
19,345

 
11,575

Less unearned income, net
 
(7,337
)
 
(4,549
)
Total loans, net of unearned income
 
$
1,271,457

 
$
1,082,536

Directors and executive officers of the Company, including their immediate families and companies in which they have an interest, may be loan customers in the normal course of business. The Company had one commitment and three commitments, respectively, totaling $7.5 million to these parties at September 30, 2014 and December 31, 2013.
The Bank makes loans under the Small Business Administration (SBA) and United States Department of Agriculture (USDA) programs. At September 30, 2014 and December 31, 2013, the outstanding balances of these loans being serviced were $126.1 million and $114.6 million, respectively. The SBA/USDA guaranteed portions of eight and 21 of these loans were sold to the secondary market during 2014 and 2013, respectively. The outstanding sold balance at September 30, 2014 and December 31, 2013, was $59.3 million and $63.1 million, respectively.
The Company accounts for loan servicing rights or liabilities under Accounting Standards Codification (ASC) 860, “Transfers and Servicing.” ASC requires the Company to recognize a servicing asset or servicing liability each time it undertakes an obligation to service a financial asset. Changes in the fair value of the servicing asset are recognized in other noninterest income. The valuation methodology estimates the present value of future cash flows based on the unique characteristics of the loan, market-based assumptions for prepayment speeds, and discount rate assumptions. The servicing asset is recorded in intangible assets in the financial statements.
See Note 15 for a summary of the activity for the Company's servicing assets.

15


Allowance for Loan Losses
The following tables summarize the activity in the allowance for loan losses during the three and nine months ended September 30, 2014 and 2013, broken out by portfolio segment:
(in thousands)
 
Three Months Ended September 30, 2014
 
 
Beginning
Balance
 
Charge
Offs
 
Recoveries
 
Provision
(Benefit)
 
Ending
Balance
Commercial loans
 
 
 
 
 
 
 
 
 
 
Technology
 
$
13,380

 
$
382

 
$
13

 
$
3,185

 
$
16,196

Life sciences
 
5,174

 
1,107

 
5

 
(1,063
)
 
3,009

Asset-based loans
 
1,363

 

 

 
501

 
1,864

Venture capital/private equity
 
143

 

 

 
71

 
214

SBA and USDA
 
614

 

 
14

 
(43
)
 
585

Other
 
11

 

 

 
(3
)
 
8

Total commercial loans
 
20,685

 
1,489

 
32

 
2,648

 
21,876

Real estate loans:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
702

 

 
217

 
(195
)
 
724

Total real estate loans
 
702

 

 
217

 
(195
)
 
724

Construction:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
19

 

 

 
4

 
23

Total construction loans
 
19

 

 

 
4

 
23

Credit cards
 
150

 

 

 
43

 
193

Total loans
 
$
21,556

 
$
1,489

 
$
249

 
$
2,500

 
$
22,816

(in thousands)
 
Three Months Ended September 30, 2013
 
 
Beginning
Balance
 
Charge
Offs
 
Recoveries
 
Provision
(Benefit)
 
Ending
Balance
Commercial loans
 
 
 
 
 
 
 
 
 
 
Technology
 
$
14,637

 
$
2,988

 
$
14

 
$
1,434

 
$
13,097

Life sciences
 
2,033

 

 

 
200

 
2,233

Asset-based loans
 
576

 

 

 
195

 
771

Venture capital/private equity
 
133

 

 

 
(9
)
 
124

SBA and USDA
 
211

 

 

 
457

 
668

Other
 
85

 

 

 
(68
)
 
17

Total commercial loans
 
17,675

 
2,988

 
14

 
2,209

 
16,910

Real estate loans:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
462

 

 

 
617

 
1,079

Total real estate loans
 
462

 

 

 
617

 
1,079

Construction:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 

 
12

 
12

Total construction loans
 

 

 

 
12

 
12

Credit cards
 
80

 

 

 
12

 
92

Total loans
 
$
18,217

 
$
2,988

 
$
14

 
$
2,850

 
$
18,093


16


(in thousands)
 
Nine Months Ended September 30, 2014
 
 
Beginning
Balance
 
Charge
Offs
 
Recoveries
 
Provision
(Benefit)
 
Ending
Balance
Commercial loans
 
 
 
 
 
 
 
 
 
 
Technology
 
$
13,609

 
$
2,548

 
$
169

 
$
4,966

 
$
16,196

Life sciences
 
1,971

 
1,516

 
5

 
2,549

 
3,009

Asset based loans
 
684

 

 

 
1,180

 
1,864

Venture capital/private equity
 
197

 

 

 
17

 
214

SBA and USDA
 
627

 
128

 
14

 
72

 
585

Other
 
2

 

 

 
6

 
8

Total commercial loans
 
17,090

 
4,192

 
188

 
8,790

 
21,876

Real estate loans:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
1,163

 
390

 
217

 
(266
)
 
724

Total real estate loans
 
1,163

 
390

 
217

 
(266
)
 
724

Construction:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
10

 

 

 
13

 
23

Total construction loans
 
10

 

 

 
13

 
23

Credit cards
 
116

 

 

 
77

 
193

Total loans
 
$
18,379

 
$
4,582

 
$
405

 
$
8,614

 
$
22,816

(in thousands)
 
Nine Months Ended September 30, 2013
 
 
Beginning
Balance
 
Charge
Offs
 
Recoveries
 
Provision
(Benefit)
 
Ending
Balance
Commercial loans
 
 
 
 
 
 
 
 
 
 
Technology
 
$
10,651

 
$
5,932

 
$
692

 
7,686

 
$
13,097

Life sciences
 
804

 

 

 
1,429

 
2,233

Asset based loans
 
1,102

 

 

 
(331
)
 
771

Venture capital/private equity
 
152

 

 

 
(28
)
 
124

SBA and USDA
 
381

 

 
150

 
137

 
668

Other
 
4

 

 

 
13

 
17

Total commercial loans
 
13,094

 
5,932

 
842

 
8,906

 
16,910

Real estate loans:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
680

 

 

 
399

 
1,079

Total real estate loans
 
680

 

 

 
399

 
1,079

Construction:
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 

 
12

 
12

Total construction loans
 

 

 

 
12

 
12

Credit cards
 
69

 

 

 
23

 
92

Total loans
 
$
13,843

 
$
5,932

 
$
842

 
$
9,340

 
$
18,093




17


The following tables summarize the allowance for loan losses individually and collectively evaluated for impairment at September 30, 2014 and December 31, 2013, broken out by portfolio segment:
(in thousands)
 
September 30, 2014
 
 
Ending  Balance:
Individually
Evaluated for
Impairment
 
Ending  Balance:
Collectively
Evaluated for
Impairment
Commercial loans
 
 
 
 
Technology
 
$
7,220

 
$
8,976

Life sciences
 
1,107

 
1,902

Asset based loans
 

 
1,864

Venture capital/private equity
 

 
214

SBA and USDA
 
47

 
538

Other
 

 
8

Total commercial loans
 
8,374

 
13,502

Real estate loans:
 
 
 
 
SBA and USDA
 

 
724

Total real estate loans
 

 
724

Construction:
 
 
 
 
SBA and USDA
 

 
23

Total construction loans
 

 
23

Credit cards
 

 
193

Total loans
 
$
8,374

 
$
14,442

(in thousands)
 
December 31, 2013
 
 
Ending  Balance:
Individually
Evaluated for
Impairment
 
Ending  Balance:
Collectively
Evaluated for
Impairment
Commercial loans
 
 
 
 
Technology
 
$
4,830

 
$
7,646

Life sciences
 

 
1,894

Asset based loans
 

 
1,894

Venture capital/private equity
 

 
197

SBA and USDA
 
132

 
495

Other
 

 
2

Total commercial loans
 
4,962

 
12,128

Real estate loans:
 
 
 
 
SBA and USDA
 
481

 
682

Total real estate loans
 
481

 
682

Construction:
 
 
 
 
SBA and USDA
 

 
10

Total construction loans
 

 
10

Credit cards
 

 
116

Total loans
 
$
5,443

 
$
12,936


18


Credit Quality
The following table summarizes the aging of gross loans, broken out by portfolio segment, at September 30, 2014 and December 31, 2013. See Note 2 to the Consolidated Financial Statements in the Company's Registration Statement for a discussion of credit quality indicators.
(in thousands)
 
September 30, 2014
 
 
30-59 Days
Past Due
 
60-89 Days
Past Due
 
90+ Days
Past Due
 
Total Loans
Past Due
 
Current
 
Total Loans
 
Loans 90+  Days
Past Due
Still Accruing
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$

 
$

 
$
2,627

 
$
2,627

 
$
632,281

 
$
634,908

 
$

Life sciences
 

 

 

 

 
240,375

 
240,375

 

Asset-based loans
 

 

 

 

 
152,282

 
152,282

 

Venture capital/private equity
 

 

 

 

 
159,349

 
159,349

 

SBA and USDA
 

 

 

 

 
33,245

 
33,245

 

Other
 

 

 

 

 
5,468

 
5,468

 

Total commercial loans
 

 

 
2,627

 
2,627

 
1,223,000

 
1,225,627

 

Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 
415

 

 
415

 
31,117

 
31,532

 

Total real estate loans
 

 
415

 

 
415

 
31,117

 
31,532

 

Construction loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 

 

 
2,290

 
2,290

 

Total construction loans
 

 

 

 

 
2,290

 
2,290

 

Credit cards
 

 

 

 

 
19,345

 
19,345

 

Total loans, gross
 
$

 
$
415

 
$
2,627

 
$
3,042

 
$
1,275,752

 
$
1,278,794

 
$

(in thousands)
 
December 31, 2013
 
 
30-59 Days
Past Due
 
60-89 Days
Past Due
 
90+ Days
Past Due
 
Total Loans
Past Due
 
Current
 
Total Loans
 
Loans 90+  Days
Past Due
Still Accruing
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$
411

 
$

 
$
2,372

 
$
2,783

 
$
541,005

 
$
543,788

 
$

Life sciences
 

 

 

 

 
224,069

 
224,069

 

Asset-based loans
 

 

 

 

 
111,251

 
111,251

 

Venture capital/private equity
 

 

 

 

 
143,468

 
143,468

 

SBA and USDA
 

 

 
648

 
648

 
23,071

 
23,719

 

Other
 

 

 

 

 
1,424

 
1,424

 

Total commercial loans
 
411

 

 
3,020

 
3,431

 
1,044,288

 
1,047,719

 

Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 
1,665

 
1,665

 
25,839

 
27,504

 

Total real estate loans
 

 

 
1,665

 
1,665

 
25,839

 
27,504

 

Construction loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 

 

 
287

 
287

 

Total construction loans
 

 

 

 

 
287

 
287

 

Credit cards
 

 

 
95

 
95

 
11,480

 
11,575

 

Total loans, gross
 
$
411

 
$

 
$
4,780

 
$
5,191

 
$
1,081,894

 
$
1,087,085

 
$


19


The following tables summarize impaired loans as they relate to allowance for loan losses, broken out by portfolio segment, at September 30, 2014 and December 31, 2013:
 
(in thousands)
 
September 30, 2014
 
 
 
Allowance for
loan  losses related
to impaired loans
 
Impaired loans  with
related allowance
for loan losses
 
Impaired loans  with
no related allowance
for loan losses
 
Recorded
investment  in
impaired loans
 
Total of  unpaid
principal of
impaired loans
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$
7,220

 
$
10,131

 
$
296

 
$
10,427

 
$
12,784

 
Life Sciences
 
1,107

 
1,107

 

 
1,107

 
2,225

 
SBA and USDA
 
47

 
264

 

 
264

 
387

 
Total commercial loans
 
8,374

 
11,502

 
296

 
11,798

 
15,396

 
Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 

 

 

 
Total real estate loans
 

 

 

 

 

 
Total loans, gross
 
$
8,374

 
$
11,502

 
$
296

 
$
11,798

 
$
15,396

 
(in thousands)
 
December 31, 2013
 
 
 
Allowance for
loan  losses related
to impaired loans
 
Impaired loans  with
related allowance
for loan losses
 
Impaired loans with
no related allowance
for loan losses
 
Recorded
investment  in
impaired loans
 
Total of  unpaid
principal of
impaired loans
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$
4,830

 
$
12,153

 
$

 
$
12,153

 
$
13,745

 
SBA and USDA
 
132

 
648

 

 
648

 
648

 
Total commercial loans
 
4,962

 
12,801

 

 
12,801

 
14,393

 
Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
481

 
1,665

 

 
1,665

 
1,665

 
Total real estate loans
 
481

 
1,665

 

 
1,665

 
1,665

 
Total loans, gross
 
$
5,443

 
$
14,466

 
$

 
$
14,466

 
$
16,058


20


The following table summarizes average impaired loans, broken out by portfolio segment, during the three and nine months ended September 30, 2014 and 2013:
 
(in thousands)
 
Three Months Ended September 30,
 
 
 
2014
 
2013
 
 
 
Average  recorded
investment in
impaired loans
 
Interest  income
recognized
 
Average  recorded
investment in
impaired loans
 
Interest  income
recognized
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
Technology
 
$
10,427

 
$

 
$
12,423

 
$

 
Life sciences
 
1,107

 

 

 

 
SBA and USDA
 
265

 

 
1,031

 

 
Total commercial loans
 
11,799

 

 
13,454

 

 
Real estate loans:
 
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 

 

 
Total real estate loans
 

 

 

 

 
Total loans, gross
 
$
11,799

 
$

 
$
13,454

 
$

 
(in thousands)
 
Nine Months Ended September 30,
 
 
 
2014
 
2013
 
 
 
Average  recorded
investment in
impaired loans
 
Interest  income
recognized
 
Average  recorded
investment in
impaired loans
 
Interest  income
recognized
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
Technology
 
$
8,523

 
$

 
$
14,517

 
$

 
Life sciences
 
1,285

 

 

 

 
SBA and USDA
 
566

 

 
589

 

 
Total commercial loans
 
10,374

 

 
15,106

 

 
Real estate loans:
 
 
 
 
 
 
 
 
 
SBA and USDA
 
856

 

 

 

 
Total real estate loans
 
856

 

 

 

 
Credit cards
 
3

 

 

 

 
Total loans, gross
 
$
11,233

 
$

 
$
15,106

 
$


21


The following table summarizes the credit quality indicators, broken out by portfolio segment, at September 30, 2014 and December 31, 2013:
(in thousands)
 
September 30, 2014
 
 
Pass
 
Performing
(Criticized)
 
Impaired
 
Total
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
569,619

 
$
54,862

 
$
10,427

 
$
634,908

Life sciences
 
228,872

 
10,396

 
1,107

 
240,375

Asset-based loans
 
124,863

 
27,419

 

 
152,282

Venture capital/private equity
 
159,349

 

 

 
159,349

SBA and USDA
 
32,718

 
263

 
264

 
33,245

Other
 
2,282

 
3,186

 

 
5,468

Total commercial loans
 
1,117,703

 
96,126

 
11,798

 
1,225,627

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 
24,140

 
7,392

 

 
31,532

Total real estate loans
 
24,140

 
7,392

 

 
31,532

Construction loans:
 
 
 
 
 
 
 
 
SBA and USDA
 
2,290

 

 

 
2,290

Total construction loans
 
2,290

 

 

 
2,290

Credit cards
 
19,345

 

 

 
19,345

Total loans, gross
 
$
1,163,478

 
$
103,518

 
$
11,798

 
$
1,278,794

(in thousands)
 
December 31, 2013
 
 
Pass
 
Performing
(Criticized)
 
Impaired
 
Total
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
475,531

 
$
56,104

 
$
12,153

 
$
543,788

Life sciences
 
210,257

 
13,812

 

 
224,069

Asset-based loans
 
110,184

 
1,067

 

 
111,251

Venture capital/private equity
 
143,468

 

 

 
143,468

SBA and USDA
 
22,063

 
1,008

 
648

 
23,719

Other
 
1,424

 

 

 
1,424

Total commercial loans
 
962,927

 
71,991

 
12,801

 
1,047,719

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 
19,852

 
5,987

 
1,665

 
27,504

Total real estate loans
 
19,852

 
5,987

 
1,665

 
27,504

Construction loans:
 
 
 
 
 
 
 
 
SBA and USDA
 
287

 

 

 
287

Total construction loans
 
287

 

 

 
287

Credit cards
 
11,575

 

 

 
11,575

Total loans, gross
 
$
994,641

 
$
77,978

 
$
14,466

 
$
1,087,085

Troubled debt restructurings (“TDRs”)
Uncollateralized loans are measured for impairment based on the present value of expected future cash flows, discounted at the historical effective interest rate, while all collateral-dependent loans are measured for impairment based on the fair value of the collateral.

22


The following table summarizes our loans classified as TDRs, broken out by portfolio segment, during the three and nine months ended September 30, 2014:
(dollars in thousands)
 
Three Months Ended September 30, 2014
 
 
Modifications
 
TDRs That
Subsequently Defaulted
 
 
Number of
Contracts
 
Pre-Modification
Outstanding
Recorded
Investment
 
Post-Modification
Outstanding
Recorded
Investment
 
Number of
Contracts
 
Recorded
Investment
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Life Sciences
 
1

 
$
2,214

 
$
1,107

 

 
$

Total commercial loans
 
1

 
2,214

 
1,107

 

 

Total loans, gross
 
1

 
$
2,214

 
$
1,107

 

 
$

The loan identified as a TDR during the three and nine months ended September 30, 2014, was restructured to defer interest payments. The loan is considered a nonperforming loan and, as such, was individually considered for allowance for loan losses calculations.
The following table summarizes our loans classified as TDRs, broken out by portfolio segment, during the three and nine months ended September 30, 2013:
(dollars in thousands)
 
Modifications
 
TDRs That
Subsequently Defaulted
 
 
Number of
Contracts
 
Pre-Modification
Outstanding
Recorded
Investment
 
Post-Modification
Outstanding
Recorded
Investment
 
Number of
Contracts
 
Recorded
Investment
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Technology
 
1

 
$
2,540

 
$
2,540

 

 
$

Total commercial loans
 
1

 
2,540

 
2,540

 

 

Total loans, gross
 
1

 
$
2,540

 
$
2,540

 

 
$

The loan identified as a TDR during the three and nine months ended September 30, 2013, was restructured to a below market interest rate. The loan is considered a nonperforming loan and, as such, was individually considered for allowance for loan losses calculations.
The Bank currently has no commitments to lend to borrowers with loans identified as TDRs.
5.
INTANGIBLE ASSETS
The Bank recognizes servicing right intangibles related to obligations to service financial assets. See Note 15 for information about the Company's servicing assets. The Bank acquired certain intangible assets, consisting of non-compete agreements and existing customer relationships, as part of its acquisition of Sand Hill Finance LLC on December 31, 2013. The non-compete agreements and existing customer relationships are finite-lived intangible assets subject to amortization. The non-compete agreements intangible asset has a one-year amortization period and the existing customer relationships intangible asset has a three-year amortization period. The acquired intangible assets do not have renewal or extension provisions.

23


The Company's finite-lived intangible assets at September 30, 2014 and December 31, 2013, are as follows:
(in thousands)
 
September 30, 2014
 
December 31, 2013
Non-compete agreements
 
$
210

 
$
210

Existing customer relationships
 
590

 
590

Total gross carrying amounts
 
800

 
800

Accumulated amortization - non-compete agreements
 
(157
)
 

Accumulated amortization - existing customer relationships
 
(148
)
 

Total accumulated amortization
 
(305
)
 

Total intangible assets subject to amortization, net
 
$
495

 
$
800

Amortization expense, net of tax for the three and nine months ended September 30, 2014, amounted to $62 thousand and $187 thousand, respectively, and is included in other noninterest expense on the accompanying consolidated statements of operations.
The following table shows the expected amortization for the next five years for intangible assets at September 30, 2014:
(in thousands)
 
 
2014
 
$
101

2015
 
197

2016
 
197

 
 
$
495

6.
DEPOSITS
Time deposits in denominations of $100,000 or more were approximately $16.2 million and $26.6 million at September 30, 2014 and December 31, 2013, respectively. Interest expense paid on time deposits individually exceeding $100,000 totaled $16 thousand and $46 thousand for the three and nine months ended September 30, 2014, respectively. Interest expense paid on time deposits individually exceeding $100,000 totaled $17 thousand and $45 thousand for the three and nine months ended September 30, 2013, respectively. At September 30, 2014, time deposits scheduled to mature on or before September 30, 2015, totaled $15.2 million.
7.
REPURCHASE AGREEMENTS AND REVERSE REPURCHASE AGREEMENTS
Securities purchased under agreements to resell generally mature within one to four days from the transaction date. Securities purchased under reverse repurchase agreements, which are included in cash and cash equivalents in the interim consolidated balance sheets, were $10.0 million at September 30, 2014. The Company had no reverse repurchase agreements outstanding at December 31, 2013.
Securities sold under agreements to repurchase generally mature within one to four days from the transaction date. Securities sold under agreements to repurchase are reflected at the amount of cash received in connection with the transaction. The Company may be required to provide additional collateral based on the fair value of the underlying securities. The Company had no repurchase agreements outstanding at September 30, 2014. Repurchase agreements outstanding at December 31, 2013, were $12.7 million.
8.
BORROWINGS
The Company may purchase federal funds through unsecured federal funds lines of credit totaling $60.0 million. These lines of credit are intended for short-term borrowings and are subject to restrictions limiting the frequency and terms of advances. These lines of credit are payable on demand and bear interest based upon the daily federal funds rate. The Company also has the ability to utilize short-term borrowings from the Federal Reserve Bank with interest based upon the Federal Reserve US Primary Credit Discount Rate. This $84.4 million line is secured by loans and investment securities. There were no outstanding borrowings for these lines at September 30, 2014 and December 31, 2013.
In addition, the Company has the ability to borrow longer term from the Federal Home Loan Bank ("FHLB"), with a $199.0 million line of credit available. The rate on these advances varies based on borrowing terms. Advances from this line of credit must be adequately collateralized with securities. There were no outstanding borrowings for this line at September 30, 2014 and December 31, 2013.

24


In September 2008, the Company issued $7.4 million of convertible trust preferred securities. These securities were placed through the Trust. The Trust held, as its sole asset, the subordinated debentures issued by the Company. The Company did not consolidate the Trust into its consolidated financial statements. The subordinated debentures issued by the Company amounted to $7.6 million. A debt discount of $1.5 million was recorded and was to be amortized over 30 years. At December 31, 2013, the remaining balance of the subordinated debentures, including respective remaining debt discount of $1.4 million, was $6.2 million. The Company notified the holders of all trust preferred securities of its intent to redeem such securities as of June 30, 2014, and all remaining outstanding trust preferred securities were converted by the holders into shares of Company common stock prior to that date. At September 30, 2014, no convertible trust preferred securities remained outstanding, and the Trust has been dissolved.
During the nine months ended September 30, 2014, investors converted $7.4 million of the outstanding convertible trust preferred securities into 741,500 common shares at $10.00 per share. For the nine months ended September 30, 2014, interest expense on the trust preferred securities was $215 thousand. For the three and nine months ended September 30, 2013, interest expense on the trust preferred securities was $158 thousand and $475 thousand, respectively.
9.
EQUITY
Preferred Stock
In December 2008, the Company issued 5,000 shares of Series A, 5% Fixed Rate Cumulative Convertible Preferred Stock. Dividends were paid quarterly, in arrears.
The preferred stock was convertible into shares of the Company’s common stock at the option of the holder and had a conversion price of $10.00 per share. At December 31, 2013, the Series A convertible preferred stock could be converted into 500,000 shares of common stock of the Company. On April 2, 2014, all shares of preferred stock were converted by the holder into 500,070 shares of common stock.
Issuances of Common Stock
During the three and nine months ended September 30, 2014, the Company issued 743 shares and 43,073 shares, respectively, of common stock related to vesting of restricted stock units issued under the Company's stock-based incentive compensation plan, and issued 72,960 shares and 191,690 shares, respectively, of common stock related to the exercise of stock options issued under the stock-based incentive compensation plan.
During the three and nine months ended September 30, 2014, the Company issued 4,000 shares and 36,000 shares, respectively, of common stock related to the exercise of warrants issued to certain individuals in 2005 in connection with the organization of the Bank.
On March 31, 2014, the Company sold a total of 3,125,000 shares of Class A common stock in our initial public offering at an initial public offering price of $18.00 and received net proceeds of $51.1 million after expenses. On April 1, 2014, the underwriters exercised in full the underwriters’ purchase option granted in connection with the initial public offering, at the initial public offering price of $18.00, resulting in an additional 468,750 shares purchased from us for which we received $7.9 million in net proceeds on April 4, 2014.
During the nine months ended September 30, 2014, the Company issued 741,500 common shares of its Class A common stock in connection with the conversion of $7.4 million of our outstanding convertible trust preferred securities into common shares at the conversion price of $10.00 per share. At September 30, 2014, no convertible trust preferred securities remained outstanding.
Earnings Per Share
Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur if convertible preferred stock, convertible trust preferred securities, stock options or warrants were exercised, resulting in the issuance of common stock that then shared in the net income of the Company.

25


Our basic and diluted earnings per common share are calculated as follows:
(in thousands except per share data)
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
 
 
2014
 
2013
 
2014
 
2013
Basic:
 
 
 
 
 
 
 
 
Net income
 
$
8,752

 
$
6,968

 
$
24,651

 
$
15,443

Less:
 dividends on preferred stock
 

 
62

 
63

 
188

Net income attributable to common shares
 
8,752

 
6,906

 
24,588

 
15,255

Basic weighted-average common shares outstanding
 
28,681

 
23,501

 
26,931

 
23,496

Earnings per share—basic
 
$
0.31

 
$
0.29

 
$
0.91

 
$
0.65

Diluted:
 
 
 
 
 
 
 
 
Net income attributable to common shares
 
$
8,752

 
$
6,906

 
$
24,588

 
$
15,255

Plus:
dividends on preferred stock
 

 

 
63

 

 
convertible trust preferred securities
 

 

 
146

 

Net income attributable to common shares after assumed conversions
 
8,752

 
6,906

 
24,797

 
15,255

Basic weighted-average common shares outstanding
 
28,681

 
23,501

 
26,931

 
23,496

Effect of dilutive stock options and warrants(1)
 
1,090

 
362

 
1,503

 
326

Diluted weighted-average common shares outstanding
 
29,771

 
23,863

 
28,434

 
23,822

Earnings per share—diluted
 
$
0.29

 
$
0.29

 
$
0.87

 
$
0.64

(1)
Excludes anti-dilutive warrants, preferred stock and trust preferred securities representing 1,311,500 shares at September 30, 2013. There were no anti-dilutive warrants, preferred stock and trust preferred securities at September 30, 2014.
In 2010, in connection with a private placement of Company common stock, the Company issued warrants to purchase 750,000 shares of common stock at any time. The exercise price of the warrants is $5.15 per share. Half of the warrants expire on February 23, 2015. The remainder expire on May 20, 2015. These warrants were valued at $1.8 million using a Black-Scholes-Merton fair value model and are included in additional paid in capital in the accompanying consolidated balance sheet.
In 2005, the Company's organizers received warrants to purchase one additional share of common stock for every share of common stock purchased. These warrants expire 10 years after issuance. At September 30, 2014 and December 31, 2013, there were 34,000 warrants and 70,000 warrants, respectively, outstanding with an exercise price of $10.00 per share.
Accumulated Other Comprehensive Income (Loss)
The Company’s only components of accumulated other comprehensive income (loss) relate to unrealized gains and losses on available for sale securities and their related tax effects. Reclassification adjustments out of accumulated other comprehensive income for the three and nine months ended September 30, 2014 and 2013 are presented in the following table:
(in thousands)
 
 
 
Three Months Ended September 30,
 
Nine Months Ended 
 September 30,
 
 
Location
 
2014
 
2013
 
2014
 
2013
Reclassification adjustment for losses (gains) included in net income
 
Net (loss) gain on securities
 
$
231

 
$
(1,411
)
 
$
165

 
$
(2,118
)
Related tax (expense) benefit
 
Income tax expense
 
(86
)
 
524

 
(62
)
 
786

Other comprehensive income (loss)
 
 
 
$
145

 
$
(887
)
 
$
103

 
$
(1,332
)
10.
INCOME TAXES
The Company and its subsidiaries file a consolidated U.S. federal income tax return. The Company is generally no longer subject to the assessment of tax with respect to returns that have been filed for years prior to 2009.

26


Realization of the Company’s net deferred tax assets is dependent upon the Company generating sufficient taxable income in future years to obtain a benefit from the reversal of deductible temporary differences and from tax loss carry-forwards. The Company has concluded that, based on expected future results and the future reversals of existing taxable temporary differences, it is more likely than not that its deferred tax assets will be realized, except for a $0.3 million valuation allowance for North Carolina. The Company’s net operating loss carry-forwards will begin to expire in 2029.
The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more-likely-than-not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. At September 30, 2014 and December 31, 2013, the Company did not record a liability for uncertain tax positions because no material positions existed.
The Company classifies tax related interest and penalties as a component of income taxes. Interest and penalties for all periods presented were immaterial.
11.
REGULATORY MATTERS AND RESTRICTIONS
The Company and the Bank are subject to various regulatory capital requirements administered by the federal and state banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and possibly additional discretionary, actions by regulators that, if undertaken, could have a direct material effect on the consolidated financial statements. Quantitative measures established by regulation to ensure capital adequacy require the Bank to maintain minimum amounts and ratios, as set forth in the table below. Management believes that at September 30, 2014, the Company and the Bank met all capital requirements to which they are subject and are “well-capitalized”.
The Bank, as a North Carolina banking corporation, may pay dividends only out of undivided profits as determined pursuant to North Carolina General Statutes Section 53-87. Regulatory authorities may further limit payment of dividends by any bank when it is determined that such a limitation is in the public interest and is necessary to ensure financial soundness of the bank.
The Company’s actual capital amounts and ratios at September 30, 2014 and December 31, 2013, and the minimum capital requirements, are presented in the following table:
(dollars in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Minimum Requirements to be:
COMPANY
 
Actual
 
Adequately Capitalized
 
Well Capitalized
 
 
Amount
 
Ratio
 
Amount    
 
Ratio    
 
Amount
 
Ratio
September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
Total risk-based capital ratio
 
$
309,000

 
14.84
%
 
$
166,620

 
8.00
%
 
$
208,275

 
10.00
%
Tier 1 risk-based capital ratio
 
285,154

 
13.69

 
83,310

 
4.00

 
124,965

 
6.00

Tier 1 leverage ratio
 
285,154

 
10.05

 
113,513

 
4.00

 
141,892

 
5.00

December 31, 2013
 
 
 
 
 
 
 
 
 
 
 
 
Total risk-based capital ratio
 
$
217,345

 
12.46
%
 
$
139,532

 
8.00
%
 
$
174,415

 
10.00
%
Tier 1 risk-based capital ratio
 
198,430

 
11.38

 
69,766

 
4.00

 
104,649

 
6.00

Tier 1 leverage ratio
 
198,430

 
8.34

 
95,205

 
4.00

 
119,007

 
5.00


27


The Bank’s actual capital amounts and ratios at September 30, 2014 and December 31, 2013, and the minimum capital requirements, are presented in the following table:
(dollars in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Minimum Requirements to be:
BANK
 
Actual
 
Adequately Capitalized
 
Well Capitalized
 
 
Amount
 
Ratio
 
Amount    
 
Ratio    
 
Amount
 
Ratio
September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
Total risk-based capital ratio
 
$
302,576

 
14.54
%
 
$
166,428

 
8.00
%
 
$
208,036

 
10.00
%
Tier 1 risk-based capital ratio
 
278,730

 
13.40

 
83,214

 
4.00

 
124,821

 
6.00

Tier 1 leverage ratio
 
278,730

 
9.83

 
113,400

 
4.00

 
141,750

 
5.00

December 31, 2013
 
 
 
 
 
 
 
 
 
 
 
 
Total risk-based capital ratio
 
$
212,821

 
12.21
%
 
$
139,385

 
8.00
%
 
$
174,231

 
10.00
%
Tier 1 risk-based capital ratio
 
193,906

 
11.13

 
69,692

 
4.00

 
104,539

 
6.00

Tier 1 leverage ratio
 
193,906

 
8.16

 
95,053

 
4.00

 
118,817

 
5.00

12.
RETIREMENT PLAN
The Company approved in January 2006 the establishment of an employee benefit plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code for the benefit of its employees. The Plan includes provisions for discretionary employee contributions, subject to limitation under the Internal Revenue Code. Under the Plan, employees may contribute up to an annual maximum as determined by the Internal Revenue Code. During 2014 and 2013, the Company matched 100% of the first 3% of employee contributions and 50% on contributions between 3-5%. The expense related to the plan for the three and nine months ended September 30, 2014, amounted to $0.2 million and $0.8 million, respectively. The expense related to the plan for the three and nine months ended September 30, 2013, amounted to $0.2 million and $0.6 million, respectively.
13.
STOCK-BASED COMPENSATION PLAN
The Company maintains a stock-based incentive compensation plan covering certain officers, directors and employees. Grants of options are made by the Compensation Committee of the Board of Directors. Excluding minimal exceptions, all grants must be at no less than fair market value on the date of grant, must be exercised no later than seven years from the date of grant, and may be subject to some vesting provisions. Grants generally vest over five years from the date of grant. The 2009 Stock Incentive Plan, as amended, provides for the issuance of up to 2,820,542 restricted stock units and options to purchase shares of the Company’s stock. At September 30, 2014, 920,119 shares of common stock remained available for future issuance through stock options or restricted stock units.
The following table presents a rollforward of the Company’s stock options outstanding during the nine months ended September 30, 2014:
 
 
 
 
 
 
Weighted
Average
Remaining
Contractual
Life in
Years
 
 
Shares
 
Weighted Average Exercise Price
 
Outstanding at beginning of period
 
1,394,550

 
$
6.12

 
4.24

Granted
 

 

 

Exercised
 
(191,690
)
 
6.08

 


Forfeited
 
(14,120
)
 
6.00

 


Outstanding at end of period
 
1,188,740

 
$
6.12

 
3.65

Options exercisable at period end
 
801,240

 
$
6.06

 
3.58


28


The following table provides information for restricted stock units issued under the stock-based incentive compensation plan during the nine months ended September 30, 2014:
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Nonvested at beginning of period
 
532,460

 
$
8.03

Granted
 
141,757

 
14.51

Vested
 
(47,855
)
 
10.70

Forfeited
 
(30,804
)
 
9.80

Nonvested at end of period
 
595,558

 
$
9.26

The Company’s pre-tax compensation cost for stock-based employee compensation was $0.7 million and $2.4 million for the three and nine months ended September 30, 2014, respectively. The Company’s pre-tax compensation cost for stock-based employee compensation was $0.4 million and $1.1 million for the three and nine months ended September 30, 2013, respectively. At September 30, 2014, there was $4.6 million of unrecognized compensation cost related to non-vested stock-based compensation under this plan to be recognized over five years.
14.
DERIVATIVES
The Company receives equity warrants with net settlement terms in connection with extending loan commitments to certain of its customers. These warrants are obtained at the inception of a loan facility or the amendment of a loan facility. These warrants are not obtained in lieu of other fees, interest or payments. These warrants potentially provide an additional return, in addition to the traditional loan yield from interest and fees, in the event of a liquidity event of the borrowing company. We hold these equity warrants for future investment gains, rather than to hedge economic risks. In general, the equity warrants entitle the Company to buy a specific number of shares of the customer’s stock at a specific price over a specific time period. The warrants may also include contingent provisions which provide for additional shares to be purchased at a specific price if defined future events occur, such as future rounds of equity financing by the customer, or upon additional borrowings by the customer. All of the Company’s equity warrants contain net share settlement provisions, which permit the customer to deliver to the Company, upon the Company’s exercise of the warrant, the amount of shares with a current fair value equal to the net gain under the warrant agreement.
ASC 815 Derivatives and Hedging requires that all derivative instruments be recorded on the balance sheet at fair value. Equity warrants with net share settlement provisions are considered derivatives. Our equity warrants portfolio is primarily comprised of holdings in non-public companies and generally our practice is to monetize our positions as soon as an open market is available. The Bank estimates the initial fair value of non-public company equity warrants using a Black-Scholes option pricing model to approximate fair market value. The model estimates market value for each warrant based on the most recent equity offering at the time of issuance, the warrant specific exercise price, the warrant’s expected life, a risk-free interest rate based on a duration matched U.S. Treasury rate and volatility factors derived from indices of comparable publicly traded companies. On a monthly basis, the Bank adjusts the value of equity warrants in non-public companies using a Black-Scholes model to approximate fair market value based on changes to the risk-free interest rate, the volatility rate and the warrant’s expected life.
We also hold warrants in public companies. When a private company goes public there is often a lock-up period requiring us to hold our equity position in a publicly traded security until the expiration of the lock-up period. We adjust the value of equity warrants in public companies on a monthly basis based on the month-end closing stock price adjusted for the option value of the warrant. The model estimates market value for each warrant based on the share price as of the evaluation date, the warrant specific exercise price, the warrant’s expected life, a risk-free interest rate based on a duration matched U.S. Treasury rate and uses a company specific volatility factor. See Note 17 for further information regarding the fair value of our equity warrants. Any changes from the grant date in the fair value of equity warrant assets will be recognized as increases or decreases to warrant valuation and as unrealized gains or losses in non-interest income. When a portfolio company completes an initial public offering on a publicly reported market or is acquired, we may exercise these equity warrant assets for shares or cash. Shares received from the exercise of warrants and subject to lock-up agreements are held as equity securities in our available for sale portfolio.
The grant date fair values of equity warrants received in connection with extending loan commitments are considered to be loan fees and are recognized over the life of the loan commitment as an adjustment to loan yield through loan interest income. At September 30, 2014 and December 31, 2013, unearned income on loans included $1.4 million and $1.2 million, respectively, related to the initial valuation of equity warrant assets. For the three and nine months ended September 30,

29


2014, we recognized $0.3 million and $0.9 million, respectively, in income from the amortization of loan fees related to the initial valuation of equity warrant assets. For the three and nine months ended September 30, 2013, we recognized $0.3 million and $0.8 million, respectively, in income from the amortization of loan fees related to the initial valuation of equity warrant assets.
Warrants held, which amounted to $4.1 million and $5.1 million in 451 and 451 companies at September 30, 2014 and December 31, 2013, respectively, are shown as warrant valuation in the accompanying consolidated balance sheets. At September 30, 2014, included in the $4.1 million in equity warrant assets in 451 companies are $0.1 million of equity warrant assets held in five publicly traded companies, which the Company intends to monetize once all restrictions to selling having been removed. At December 31, 2013, included in the $5.1 million in equity warrant assets in 451 companies are $1.0 million of equity warrant assets held in three publicly traded companies, which the Company monetized upon the expiration of all sale restrictions.
During the three and nine months ended September 30, 2014, the Company exercised warrants with a total value of $1.4 million and $2.8 million, respectively, and received equity securities in six and 10 publicly traded companies, respectively. During the three months ended September 30, 2014, the Company monetized equity securities, which we had obtained in two public companies through the exercise of warrants, for $0.7 million in proceeds. These equity securities had an initial value of $0.9 million and we recognized a loss of $0.2 million. During the nine months ended September 30, 2014, the Company monetized equity securities, which we had obtained in three public companies through the exercise of warrants, for $1.0 million in proceeds. These equity securities had an initial value of $1.2 million and we recognized a loss of $0.2 million. During the three and nine months ended September 30, 2013, the Company monetized warrants and realized a gain of $1.3 million on the exercise of warrants in one portfolio company client that conducted an IPO.
At September 30, 2014, the fair value of equity securities included in investments obtained through the exercise of warrants and still held was $1.3 million (see Note 3). The Company did not have equity securities obtained from the exercise of warrants in our available for sale portfolio in 2013.


30


The following table presents gains and losses on equity warrant exercises and the number of companies on which warrants were exercised, broken out by stage of emerging companies:
(in thousands except number of companies)
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2014
 
2013
 
2014
 
2013
Equity warrant assets:
 
 
 
 
 
 
 
Gains:
 
 
 
 
 
 
 
Early stage
$
167

 
$

 
$
1,197

 
$
456

Expansion stage
350

 
2,433

 
1,884

 
2,915

Late stage
1,296

 

 
1,750

 
672

Total gains on exercise of equity warrant assets
1,813

 
2,433

 
4,831

 
4,043

Losses:
 
 
 
 
 
 
 
Early stage

 

 
(8
)
 

Expansion stage
(8
)
 

 
(2
)
 

Total losses on exercise of equity warrant assets (1)
(8
)
 

 
(10
)
 

Net gains on exercise of equity warrant assets
1,805

 
2,433

 
4,821

 
4,043

Non-monetized write off of warrant assets
(178
)
 
(132
)
 
(354
)
 
(310
)
Net realized gains on equity warrants
1,627

 
2,301

 
4,467

 
3,733

Change in fair value of equity warrant assets
(906
)
 
(1,402
)
 
(1,530
)
 
(470
)
Warrant income
$
721

 
$
899

 
$
2,937

 
$
3,263

 
 
 
 
 
 
 
 
Number of companies on which warrant gains were realized:
 
 
 
 
 
 
 
Early stage
4

 

 
15

 
3

Expansion stage
8

 
9

 
25

 
18

Late stage
3

 

 
8

 
2

Total number of companies
15

 
9

 
48

 
23

(1) Realized warrant losses for the three months ended September 30, 2014, related to one early stage company, and for the three and nine months ended September 30, 2014, related to one early stage company and one expansion stage company.
15.
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES
Fair Value Measurements
Our marketable investment securities and derivative instruments are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our consolidated financial statements. ASC 825-10 provides an option to report selected financial assets and liabilities at fair value. The Company has not elected to measure any financial assets or liabilities using the fair value option under ASC 825-10.
ASC 820, Fair Value Measurements and Disclosures defines fair value as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. Fair value is a market-based measurement considered from the perspective of a market participant who holds the asset or owes the liability rather than an entity-specific measurement.
ASC 820 establishes a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable. Observable inputs reflect market-derived or market-based information obtained from independent sources, while unobservable inputs reflect our estimates about market data.

31


The three levels for measuring fair value are based on the reliability of inputs and are as follows:
Level 1
  
Valuations based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Valuation adjustments and block discounts are not applied to instruments utilizing Level 1 inputs. Since valuations are based on quoted prices that are readily available in an active market, valuation of these products does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include exchange-traded equity securities.
Level 2
  
Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Assets and liabilities utilizing Level 2 inputs include: U.S. treasury and agency securities, mortgage-backed securities, collateralized mortgage obligations, commercial mortgage-backed securities, municipal bonds and notes, Over-the-Counter (“OTC”) derivative instruments (foreign exchange forwards and option contracts, interest rate swaps related to our senior notes, subordinated notes and junior subordinated debentures), and equity warrant assets for shares of public company capital stock.
 
 
Level 3
  
Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Assets utilizing Level 3 inputs include: limited partnership interests in private equity funds, direct equity investments in private companies, mortgage-backed securities, and equity warrant assets for shares of private company capital stock.
For inactive markets, there is little information, if any, to evaluate if individual transactions are orderly. Accordingly, we are required to estimate, based upon all available facts and circumstances, the degree to which orderly transactions are occurring. Price quotes based upon transactions that are not orderly are not considered to be determinative of fair value and are given little, if any, weight in measuring fair value. Price quotes based upon transactions that are orderly are considered in determining fair value, with the weight given based upon the facts and circumstances. If sufficient information is not available to determine if price quotes are based upon orderly transactions, less weight is given to the price quote relative to other transactions that are known to be orderly.
To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment that we use to determine fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes the level in the fair value hierarchy within which the fair value measurement is determined is based on the lowest level input that is significant to the fair value measurement in its entirety.
Investment securities are recorded at fair value on a recurring basis. Fair value measurement is based upon quoted market prices, if available. If quoted market prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions.
The types of instruments valued based on quoted market prices in active markets include the Company’s U.S. government and agency securities, mortgage-backed securities and asset-backed securities (“ABS”). Such instruments are generally classified within level 1 or level 2 of the fair value hierarchy. As required by ASC 820, the Company does not adjust the quoted price for such instruments.
Level 3 valuations are for instruments that are not traded in active markets or are subject to transfer restrictions, and may be adjusted to reflect illiquidity and/or non-transferability, with such adjustment generally based on available market evidence. In the absence of such evidence, management’s best estimate is used. Such instruments in this category include some investment securities, all impaired loans, warrants and foreclosed assets.
Transfers between fair value hierarchy levels would represent assets or liabilities that were previously categorized at a higher level for which the inputs to the estimate became less observable or classified at a lower level for which the inputs became more observable during the period. The Company's policy is to recognize transfers between levels at the end of the period.

32


Following is a summary of the valuation techniques used for each class of Level 3 assets:
(dollars in thousands)
 
September 30, 2014
 
 
Fair Value
 
Valuation Technique
 
Unobservable Input
Available for sale securities:
 
 
 
 
 
 
Corporates
 
$

 
Sensitivity analyses
 
Indicative pricing
Non-Agency MBS
 
132,887

 
Volatility-driven, multi-dimensional spread tables, optional adjusted spread model and prepayment model
 
Indicative pricing, collateral performance
Other ABS
 
49,008

 
Multi-dimensional, collateral specific spread tables
 
Indicative pricing, collateral performance
Warrants
 
4,089

 
Black-Scholes option pricing model
 
Estimated market price, stated strike prices, option expiration prices, risk-free interest rates, option volatility assumptions
Servicing asset
 
1,275

 
Discounted cash flow
 
Discount rates, default rates, prepayment rates, servicing costs
Venture capital fund investments
 
4,244

 
Private company equity pricing
 
Actual and forecasted results, cash position, market comparable companies
(dollars in thousands)
 
December 31, 2013
 
 
Fair Value
 
Valuation Technique
 
Unobservable Input
Available for sale securities:
 
 
 
 
 
 
Corporates
 
$
26,301

 
Sensitivity analyses
 
Indicative pricing
Non-Agency MBS
 
52,170

 
Volatility-driven, multi-dimensional spread tables, optional adjusted spread model and prepayment model
 
Indicative pricing, collateral performance
Other ABS
 
22,091

 
Multi-dimensional, collateral specific spread tables
 
Indicative pricing, collateral performance
Warrants
 
5,105

 
Black-Scholes option pricing model
 
Estimated market price, stated strike prices, option expiration prices, risk-free interest rates, option volatility assumptions
Servicing asset
 
1,265

 
Discounted cash flow
 
Discount rates, default rates, prepayment rates, servicing costs
Venture capital fund investments
 
4,066

 
Private company equity pricing
 
Actual and forecasted results, cash position, market comparable companies

33


Following are tables that present information about our investment securities, warrants, servicing asset, and venture capital fund investments, measured at fair value on a recurring basis:
(in thousands)
 
At September 30, 2014
 
 
Quoted Prices in
Active Markets for
Identical Assets
 
Significant Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
Ending
Balance
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Available for sale securities:
 
 
 
 
 
 
 
 
US Treasuries
 
$
19,662

 
$

 
$

 
$
19,662

Agency Direct Obligations
 
34,647

 

 

 
34,647

SBA Pools
 

 
145,041

 

 
145,041

Agency MBS
 

 
584,038

 

 
584,038

Corporates
 

 
121,025

 

 
121,025

Municipal Bonds
 

 
98,126

 

 
98,126

Non-Agency MBS
 

 

 
132,887

 
132,887

Other ABS
 

 

 
49,008

 
49,008

Equity securities
 
2,453

 

 

 
2,453

Total available for sale securities
 
$
56,762

 
$
948,230

 
$
181,895

 
$
1,186,887

Warrants
 
$

 
$

 
$
4,089

 
$
4,089

Servicing asset
 
$

 
$

 
$
1,275

 
$
1,275

Venture capital fund investments
 
$

 
$

 
$
4,244

 
$
4,244

(in thousands)
 
At December 31, 2013
 
 
Quoted Prices in
Active Markets for
Identical Assets
 
Significant Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
Ending
Balance
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Available for sale securities:
 
 
 
 
 
 
 
 
Agency Direct Obligations
 
$
35,061

 
$

 
$

 
$
35,061

SBA Pools
 

 
129,211

 

 
129,211

Agency MBS
 

 
447,850

 

 
447,850

Corporates
 

 
119,516

 
26,301

 
145,817

Municipal Bonds
 

 
92,029

 

 
92,029

Non-Agency MBS
 

 

 
52,170

 
52,170

Other ABS
 

 

 
22,091

 
22,091

Total available for sale securities
 
$
35,061

 
$
788,606

 
$
100,562

 
$
924,229

Warrants
 
$

 
$

 
$
5,105

 
$
5,105

Servicing asset
 
$

 
$

 
$
1,265

 
$
1,265

Venture capital fund investments
 
$

 
$

 
$
4,066

 
$
4,066



34


The following tables present additional information about Level 3 securities, venture capital fund investments, servicing assets and warrants, measured at fair value on a recurring basis:
(dollars in thousands)
 
Three Months Ended September 30, 2014
 
 
Available for sale securities
 
 
 
 
 
 
 
 
 
 
Corporates
 
Non-Agency MBS
 
Other ABS
 
Venture Capital Fund Investments
 
Servicing Asset
 
Warrants
 
Total
Balance at June 30, 2014
 
$
6,085

 
$
85,434

 
$
34,047

 
$
4,333

 
$
1,325

 
$
4,747

 
$
135,971

Transfers into Level 3
 

 

 

 

 

 

 

Transfers out of Level 3
 
(6,085
)
 

 

 

 

 
(129
)
 
(6,214
)
Total gains (losses):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
included in net income
 

 

 

 
(261
)
 

 
721

 
460

included in other comprehensive income
 

 
(3,706
)
 

 

 

 

 
(3,706
)
Purchases, sales, issuances and settlements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchases
 

 
51,159

 
24,222

 
232

 

 

 
75,613

Sales
 

 

 

 

 

 
(1,782
)
 
(1,782
)
Issuances
 

 

 

 

 
56

 
532

 
588

Settlements
 

 

 
(9,261
)
 
(60
)
 
(106
)
 

 
(9,427
)
Balance at September 30, 2014
 
$

 
$
132,887

 
$
49,008

 
$
4,244

 
$
1,275

 
$
4,089

 
$
191,503

(dollars in thousands)
 
Three Months Ended September 30, 2013
 
 
Available for sale securities
 
 
 
 
 
 
 
 
 
 
Corporates
 
Non-Agency MBS
 
Other ABS
 
Venture Capital Fund Investments
 
Servicing Asset
 
Warrants
 
Total
Balance at June 30, 2013
 
$
16,584

 
$
27,592

 
$
12,211

 
$
3,156

 
$
1,142

 
$
6,330

 
$
67,015

Transfers into Level 3
 
5,138

 

 

 

 

 

 
5,138

Transfers out of Level 3
 

 

 

 

 

 

 

Total gains (losses):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
included in net income
 

 

 

 
988

 
(73
)
 
899

 
1,814

included in other comprehensive income
 

 
690

 
1,130

 

 

 

 
1,820

Purchases, sales, issuances and settlements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchases
 

 
17,657

 
8,979

 
34

 

 

 
26,670

Sales
 

 

 

 

 

 
(2,490
)
 
(2,490
)
Issuances
 

 

 

 

 
127

 
479

 
606

Settlements
 

 

 

 
(102
)
 

 

 
(102
)
Balance at September 30, 2013
 
$
21,722

 
$
45,939

 
$
22,320

 
$
4,076

 
$
1,196

 
$
5,218

 
$
100,471


35


(dollars in thousands)
 
Nine Months Ended September 30, 2014
 
 
Available for sale securities
 
 
 
 
 
 
 
 
 
 
Corporates
 
Non-Agency MBS
 
Other ABS
 
Venture Capital Fund Investments
 
Servicing Asset
 
Warrants
 
Total
Balance at December 31, 2013
 
$
26,301

 
$
52,170

 
$
22,091

 
$
4,066

 
$
1,265

 
$
5,105

 
$
110,998

Transfers into Level 3
 
2,994

 

 
2,762

 

 

 

 
5,756

Transfers out of Level 3
 
(29,474
)
 

 

 
(953
)
 

 
(1,498
)
 
(31,925
)
Total gains (losses):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
included in net income
 

 

 

 
1,154

 
18

 
2,937

 
4,109

included in other comprehensive income
 
179

 
(8,111
)
 
(7,058
)
 

 

 

 
(14,990
)
Purchases, sales, issuances and settlements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchases
 

 
91,031

 
40,474

 
402

 

 

 
131,907

Sales
 

 
(2,203
)
 

 

 

 
(3,582
)
 
(5,785
)
Issuances
 

 

 

 

 
166

 
1,127

 
1,293

Settlements
 
 
 

 
(9,261
)
 
(425
)
 
(174
)
 

 
(9,860
)
Balance at September 30, 2014
 
$

 
$
132,887

 
$
49,008

 
$
4,244

 
$
1,275

 
$
4,089

 
$
191,503

(dollars in thousands)
 
Nine Months Ended September 30, 2013
 
 
Available for sale securities
 
 
 
 
 
 
 
 
 
 
Corporates
 
Non-Agency MBS
 
Other ABS
 
Venture Capital Fund Investments
 
Servicing Asset
 
Warrants
 
Total
Balance at December 31, 2012
 
$
11,715

 
$
19,016

 
$
2,643

 
$
3,303

 
$
987

 
$
4,780

 
$
42,444

Transfers into Level 3
 
5,501

 

 

 

 

 

 
5,501

Transfers out of Level 3
 

 

 

 

 

 

 

Total gains (losses):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
included in net income
 

 

 

 
986

 
(77
)
 
3,263

 
4,172

included in other comprehensive income
 
485

 
2,185

 

 

 

 

 
2,670

Purchases, sales, issuances and settlements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchases
 
4,021

 
24,738

 
19,677

 
328

 

 

 
48,764

Sales
 

 

 

 

 

 
(4,224
)
 
(4,224
)
Issuances
 

 

 

 

 
286

 
1,399

 
1,685

Settlements
 

 

 

 
(541
)
 

 

 
(541
)
Balance at September 30, 2013
 
$
21,722

 
$
45,939

 
$
22,320

 
$
4,076

 
$
1,196

 
$
5,218

 
$
100,471

For the three and nine months ended September 30, 2014, no available for sale securities and two available for sale securities, respectively, were transferred from Level 2 due to lack of observable inputs to substantiate a Level 2 valuation. For the three and nine months ended September 30, 2013, two available for sale securities and eight available for sale securities, respectively, were transferred from Level 2 due to lack of observable inputs to substantiate a Level 2 valuation.

36


Investments in Entities that Calculate Net Asset Value Per Share
FASB guidance (ASC 825-10-50-6A) requires disclosures about the fair value measurements of investments in certain entities that calculate net asset value per share or its equivalents. These disclosures include the fair value of funds; significant investment strategies of the investees; for investments that cannot be redeemed, estimates of the time periods over which underlying assets are expected to be liquidated; the amounts of the Company's unfunded commitments; redemption features of the investments; restrictions on the ability to sell the investments; and information about sales in certain circumstances.
The Company has investments in venture capital funds that calculate net asset value per share. The Company's investments in venture capital funds generally cannot be redeemed. Alternatively, the Company expects distributions, if any, to be received primarily through M&A activity and IPOs of the underlying assets of the fund. The Company currently does not have any plans to sell any of these fund investments. If the Company decides to sell these investments in the future, generally the investee fund’s management must approve of the buyer before the sale of the investments can be completed. The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value based on the most recently available financial information from the investee general partner. The most recently available financial information is generally as of the end of the previous quarter. For example, the September 30, 2014 financial statements reflect the June 30, 2014 financial information from the investee general partner, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.
The following tables summarize the estimated fair values of these investments and remaining unfunded commitments for these investments:
(in thousands)
 
September 30, 2014
 
 
Carrying Value
 
Fair Value
 
Unfunded Commitments
Venture capital fund investments
 
$
4,244

 
$
4,244

 
$
2,025

  Total
 
$
4,244

 
$
4,244

 
$
2,025

(in thousands)
 
December 31, 2013
 
 
Carrying Value
 
Fair Value
 
Unfunded Commitments
Venture capital fund investments
 
$
4,066

 
$
4,066

 
$
1,006

  Total
 
$
4,066

 
$
4,066

 
$
1,006

Venture capital fund investments include investments made by Square 1 Financial, Inc. and Square 1 Bank. These investments represent commitments to venture capital funds that invest in or lend money to primarily U.S. and global technology and life sciences companies and invest in U.S. based venture capital funds themselves. It is estimated that the Company will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
At September 30, 2014, the $4.2 million venture capital fund investments valuation consisted of $1.3 million of Bank investments primarily for CRA purposes, $1.8 million from Square 1 Ventures, and $0.9 million of holding company investments.
Fair Value of Assets Measured on a Non-recurring Basis
Foreclosed Assets — Upon acquisition, foreclosed assets are initially recorded at the fair value of the asset less cost to sell. Any excess of the recorded investment over the fair value of the property received is charged to the allowance for loan losses. Subsequently, foreclosed assets are carried at the lower of carrying value or net realizable value. Reviews will be performed by management and any subsequent write-downs due to the excess of carrying value of a property over its estimated fair value (less estimated costs to sell) are charged against other expenses. Foreclosed assets are included in other assets in the accompanying consolidated balance sheets.

37


The following table presents information about our assets measured at fair value on a non-recurring basis:
(in thousands)
 
Quoted Prices in
Active Markets for
Identical Assets
 
Significant Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
Ending
Balance
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
September 30, 2014
 
 
 
 
 
 
 
 
Impaired loans
 
$

 
$

 
$
3,425

 
$
3,425

December 31, 2013
 
 
 
 
 
 
 
 
Foreclosed assets
 
$

 
$

 
$
119

 
$
119

Impaired loans
 
$

 
$

 
$
9,022

 
$
9,022

Financial Instruments Not Carried at Fair Value
FASB issued guidance over financial instruments (ASC 825-10-65) requires that we disclose estimated fair values for our financial instruments not carried at fair value. Fair value estimates, methods and assumptions, set forth below for our financial instruments, are made solely to comply with the requirements of ASC 825.
Fair values are based on estimates or calculations at the transaction level using present value techniques in instances where quoted market prices are not available. Because broadly traded markets do not exist for many of our financial instruments, the fair value calculations attempt to incorporate the effect of current market conditions at a specific time. Fair valuations are management’s estimates of the values, and they are calculated based on indicator prices corroborated by observable market quotes or pricing models, the economic and competitive environment, the characteristics of the financial instruments, expected losses, and other such factors.
These calculations are subjective in nature, involve uncertainties and matters of significant judgment, and do not include tax ramifications; therefore, the results cannot be determined with precision or substantiated by comparison to independent markets, and they may not be realized in an actual sale or immediate settlement of the instruments. There may be inherent weaknesses in any calculation technique, and changes in the underlying assumptions used, including discount rates and estimates of future cash flows, could significantly affect the results. For all of these reasons, the aggregation of the fair value calculations presented herein does not represent, and should not be construed to represent, the underlying value of the Company.
The following describes the methods and assumptions used in estimating the fair values of financial instruments, excluding financial instruments already recorded at fair value as described above.
Cash and due from banks, federal funds sold and short-term investments
The carrying amounts for cash and due from banks, federal funds sold and short-term investments approximate fair value because of the short maturities of those instruments.
Loans
The fair value of the net loan portfolio has been estimated based on management’s assumptions with respect to present value of expected cash flows, discounted at an interest rate giving consideration to estimated prepayment risk and credit loss factors. There is no material difference between carrying value and fair value of loans as outstanding loans are predominately at variable rates.
Investment securities—held to maturity
The fair value of investment securities held to maturity are based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly.
FHLB stock
The carrying amount of FHLB stock approximates fair value as it is not practicable to determine the fair value due to restrictions placed on its transferability.
Accrued Interest Receivable
The carrying amount of accrued interest receivable approximates fair value due to the short-term nature of the balance.

38


Deposits
The fair value of deposits with no stated maturities are predominately at variable rates and, accordingly, the fair values have been estimated to equal the carrying amounts (the amount payable on demand). The fair values of certificates of deposits are estimated by discounting the future cash flows using the current rates offered for similar deposits with the same remaining maturities.
Short-term borrowings
The Company’s short-term borrowings include securities sold under repurchase agreements, federal funds purchased and short-term lines of credit. The carrying amount is a reasonable estimate of fair value because of the relatively short time between the origination of the borrowing and its contractual maturity.
Long-term debt
The Company’s long-term debt includes the Company’s convertible subordinated debentures. Fair value of long-term debt is estimated by discounting the future cash flows using current rates offered with the same maturities, price indications from reputable dealers or utilizing observable market prices of the underlying instrument, whichever is deemed more reliable.
Financial instruments with off-balance sheet risk
With regard to financial instruments with off-balance sheet risk discussed in Note 16, carrying amounts are reasonable estimates of the fair values for such financial instruments. Commitments to extend credit generally result in loans with a market interest rate if funded.
The following tables present the estimated fair values of our financial instruments that are not carried at fair value:
(in thousands)
 
September 30, 2014
 
 
Carrying
Value
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Ending
Balance
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
185,606

 
$
185,606

 
$

 
$

 
$
185,606

Investment in time deposits
 
1,250

 
1,250

 

 

 
1,250

Investment securities—held to maturity
 
278,121

 

 
276,407

 
6,750

 
283,157

Loans, net of unearned income
 
1,271,457

 

 

 
1,277,550

 
1,277,550

FHLB stock
 
2,091

 

 

 
2,091

 
2,091

Accrued interest receivable
 
10,835

 

 

 
10,835

 
10,835

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
Non-maturity deposits(1)
 
2,651,938

 
2,651,938

 

 

 
2,651,938

Time deposits
 
16,507

 

 
16,466

 

 
16,466

Short-term borrowings
 

 

 

 

 

Long-term debt
 

 

 

 

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
 


Future financing commitments
 

 

 

 
1,167,115

 
1,167,115

(1)Includes noninterest demand deposits, interest-bearing demand deposits and money market deposits.

39


(in thousands)
 
December 31, 2013
 
 
Carrying
Value
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Ending
Balance
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
105,730

 
$
105,730

 
$

 
$

 
$
105,730

Investment in time deposits
 
1,250

 
1,250

 

 

 
1,250

Investment securities—held to maturity
 
154,255

 

 
140,254

 
6,300

 
146,554

Loans, net of unearned income
 
1,082,536

 

 

 
1,088,062

 
1,088,062

FHLB stock
 
2,162

 

 

 
2,162

 
2,162

Accrued interest receivable
 
9,023

 

 
9,023

 

 
9,023

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
Non-maturity deposits(1)
 
2,079,909

 
2,046,398

 

 

 
2,046,398

Time deposits
 
26,818

 

 
26,851

 

 
26,851

Short-term borrowings
 

 

 

 

 

Long-term debt
 
6,207

 

 
5,753

 

 
5,753

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
 


Future financing commitments
 

 

 

 
977,262

 
977,262

(1)Includes noninterest demand deposits, interest-bearing demand deposits and money market deposits.
16.
OFF-BALANCE SHEET RISK, COMMITMENTS AND CONTINGENCIES
To meet the financial needs of its customers, the Company is party to financial instruments with off-balance sheet risk in the normal course of business. These financial instruments are comprised of unfunded lines of credit and financial standby letters of credit. These instruments involve, to varying degrees, elements of credit risk in excess of the amounts recognized in the accompanying consolidated balance sheet.
The Company’s exposure to credit loss in the event of nonperformance by the other party is represented by the contractual amount of these instruments. The Company uses the same credit policies in making these commitments as it does for on-balance sheet instruments. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the borrower. Collateral held varies but may include cash in deposit accounts, trade accounts receivable, property, plant, and equipment and intellectual property. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements.
At September 30, 2014 and December 31, 2013, unfunded lines of credit were $1.2 billion and $977.3 million, respectively, and outstanding standby letters of credit amounted to $68.2 million and $89.2 million, respectively.
From time to time, the Company is party, either as a defendant or plaintiff, to lawsuits in the normal course of our business. While any litigation involves an element of uncertainty, management is of the opinion that the liability, if any, resulting from pending legal proceedings will not have a material adverse effect on our financial condition, liquidity or results of operations.


40



ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements within the meaning of section 27A of the Securities Act and 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.
There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but are not limited to, the following:
market and economic conditions (including interest rate environment, levels of public offerings, mergers and acquisitions (“M&A”) and venture capital financing activities) and the associated impact on us;
changes in management personnel;
the sufficiency of our capital, including sources of capital (such as funds generated through retained earnings) and the extent to which capital may be used or required;
our overall investment plans, strategies and activities, including our investment of excess cash/liquidity;
venture capital/private equity funding and investments;
operational, liquidity and credit risks associated with our business;
deterioration of our asset quality;
our overall management of interest rate risk, including managing the sensitivity of our interest-earning assets and interest-bearing liabilities to interest rates, and the impact to earnings from a change in interest rates;
our ability to execute our strategy and to achieve organic loan and deposit growth;
increased competition in the financial services industry, nationally, regionally or locally, which may adversely affect pricing and terms;
the adequacy of reserves (including allowance for loan and lease losses) and the appropriateness of our methodology for calculating such reserves;
the level of client investment fees and associated margins;
changes in federal tax law or policy;
volatility and direction of market interest rates;
changes in the regulatory environment;
changes in trade, monetary and fiscal policies and laws;
governmental legislation and regulation, including changes in accounting regulation or standards, the nature and timing of the adoption and effectiveness of new requirements under the Dodd-Frank Act, Basel guidelines, capital requirements and other applicable laws and regulations;
changes in interpretation of existing law and regulation;
further government intervention in the U.S. financial system; and
other factors that are discussed in the section titled “Risk Factors,” which are set forth in the Company's Registration Statement.
The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in this filing. If one or more events related to these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may differ materially from what we anticipate. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

41


The objective of this section is to help potential investors understand our views on our results of operations and financial condition. You should read this discussion in conjunction with the unaudited interim consolidated financial statements and notes thereto in this Form 10-Q and in conjunction with Square 1's consolidated balance sheets as of December 31, 2013 and 2012, and the related consolidated statements of operations and comprehensive income, changes in shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2013, and notes thereto included in the Registration Statement.
Management’s Discussion and Analysis includes financial information prepared in accordance with GAAP, as well as certain non-GAAP financial measures such as “efficiency ratio,” “tangible common equity to tangible assets,” “net operating income,” "net interest income," and "core banking noninterest income" (see "Non-GAAP Financial Measures").
Summary Financial Information
The following summary financial information is derived in part from our consolidated financial statements. The following is only a summary and you should read it in conjunction with the unaudited interim consolidated financial statements and the related notes.
(Dollars in thousands)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
2014
 
2013
Financial Condition Data:
 
(Dollars in thousands)
 
(Dollars in thousands)
Average total assets
 
$
2,838,269

 
$
2,123,359

 
$
2,620,684

 
$
1,991,599

Average cash and cash equivalents
 
157,129

 
112,915

 
166,987

 
128,721

Average investment securities - available-for-sale
 
1,133,467

 
887,213

 
1,052,298

 
850,264

Average investment securities - held-to-maturity
 
252,289

 
123,628

 
204,292

 
90,236

Average loans, net of unearned income
 
1,223,906

 
943,696

 
1,138,097

 
872,873

Average on-balance sheet deposits
 
2,533,778

 
1,900,576

 
2,349,180

 
1,776,530

Average total client investment funds
 
931,780

 
443,612

 
771,705

 
405,311

Average borrowings
 
543

 
10,988

 
3,623

 
15,876

Average repurchase agreements
 

 
22,525

 
2,009

 
7,592

Average total shareholders' equity
 
289,021

 
179,958

 
254,401

 
181,319

 
 
 
 
 
 
 
 
 
Operating Data:
 
 
 
 
 
 
 
 
Interest income
 
$
26,958

 
$
20,020

 
$
74,832

 
$
55,074

Interest expense
 
150

 
346

 
642

 
981

Net interest income
 
26,808

 
19,674

 
74,190

 
54,093

Provision for loan losses
 
2,500

 
2,850

 
8,614

 
9,340

Net interest income after provision for loan losses
 
24,308

 
16,824

 
65,576

 
44,753

Noninterest income
 
5,532

 
6,729

 
19,044

 
18,340

Noninterest expense
 
16,835

 
13,659

 
49,018

 
40,805

Income before income tax expense
 
13,005

 
9,894

 
35,602

 
22,288

Income tax expense
 
4,253

 
2,926

 
10,951

 
6,845

Preferred stock dividends and discount accretion
 

 
62

 
63

 
188

Net income available to common shareholders
 
8,752

 
6,906

 
24,588

 
15,255


42


 
 
At or For the
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
2014
 
2013
Performance Ratios:
 
 
 
 
 
 
 
 
Return on average assets
 
1.22
%
 
1.29
%
 
1.25
%
 
1.02
%
Return on average common equity
 
12.01

 
15.66

 
13.01

 
11.56

Net interest margin(1)
 
4.00

 
3.95

 
4.04

 
3.89

Efficiency ratio(2)
 
49.79

 
49.85

 
50.55

 
54.54

Average equity to average assets
 
10.18

 
8.48

 
9.71

 
9.10

 
 
 
 
 
 
 
 
 
Capital Ratios (consolidated):
 
 
 
 
 
 
 
 
Tier 1 leverage capital
 
10.05

 
9.02

 
10.05

 
9.02

Tier 1 risk-based capital
 
13.69

 
11.68

 
13.69

 
11.68

Total risk-based capital
 
14.84

 
12.79

 
14.84

 
12.79

Total shareholders’ equity to assets
 
9.85

 
8.43

 
9.85

 
8.43

Tangible common equity to tangible assets(3)
 
9.83

 
8.20

 
9.83

 
8.20

 
 
 
 
 
 
 
 
 
Asset Quality Ratios:
 
 
 
 
 
 
 
 
Allowance for loan losses as a percent of total loans
 
1.79

 
1.78

 
1.79

 
1.78

Allowance for loan losses as a percent of nonperforming loans
 
193.38

 
134.56

 
193.38

 
134.56

Net charge-offs to average outstanding loans (annualized)
 
0.40

 
1.25

 
0.49

 
0.78

Nonperforming loans as a percent of total loans
 
0.93

 
1.32

 
0.93

 
1.32

Nonperforming assets as a percent of total assets
 
0.39

 
0.63

 
0.39

 
0.63

(1)
Represents net interest income as a percent of average interest-earning assets.
(2)
Represents noninterest expense divided by the sum of net interest income and other income, excluding gains or losses on the impairment and sale of securities. Efficiency ratio, as calculated, is a non-GAAP financial measure. See “Non-GAAP Financial Measures.”
(3)
Tangible common equity to tangible assets is a non-GAAP financial measure. Tangible common equity is computed as total shareholders’ equity, excluding preferred stock, less intangible assets. Tangible assets are calculated as total assets less intangible assets other than loan servicing intangible assets. We believe that the most directly comparable GAAP financial measure is total shareholders’ equity to assets. See “Non-GAAP Financial Measures.”
Non-GAAP Financial Measures
The information set forth above contains certain financial information determined by methods other than in accordance with GAAP. Generally, a non-GAAP financial measure is a numerical measure of financial performance, financial position or cash flows that excludes (or includes) amounts that are included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP. These non-GAAP financial measures for us are “efficiency ratio,” “tangible common equity to tangible assets,” “net operating income,” "net interest income," and "core banking noninterest income." Although we believe these non-GAAP financial measures provide a greater understanding of our business, these measures are not necessarily comparable to similar measures that may be presented by other companies. The non-GAAP financial measures should be viewed as a supplement to, and not a substitute for, financial measures presented in accordance with GAAP.

43


The information provided below reconciles each non-GAAP measure to its most comparable GAAP measure:
 
 
At or For the
(Dollars in thousands)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
2014
 
2013
Efficiency Ratio
 
 
 
 
 
 
 
 
Noninterest expense (GAAP)
 
$
16,835

 
$
13,659

 
$
49,019

 
$
40,805

Net interest taxable equivalent income
 
27,867

 
20,577

 
77,186

 
56,235

Noninterest taxable equivalent income
 
5,709

 
6,889

 
19,549

 
18,755

Less: (loss) gain on sale of securities and impairment
 
(235
)
 
65

 
(231
)
 
171

Adjusted operating revenue
 
$
33,811

 
$
27,401

 
$
96,966

 
$
74,819

Efficiency ratio
 
49.79
%
 
49.85
%
 
50.55
%
 
54.54
%
 
 
 
 
 
 
 
 
 
Tangible Common Equity/Tangible Assets
 
 
 
 
 
 
 
 
Total equity
 
$
294,202

 
$
182,413

 
$
294,202

 
$
182,413

Less: preferred stock
 

 
4,950

 

 
4,950

Intangible assets(1)
 
495

 

 
495

 

Tangible common equity
 
$
293,707

 
$
177,463

 
$
293,707

 
$
177,463

Total assets
 
$
2,988,186

 
$
2,163,452

 
$
2,988,186

 
$
2,163,452

Less: intangible assets(1)
 
495

 

 
495

 

Tangible assets
 
$
2,987,691

 
$
2,163,452

 
$
2,987,691

 
$
2,163,452

Tangible common equity/tangible assets
 
9.83
%
 
8.20
%
 
9.83
%
 
8.20
%
 
 
 
 
 
 
 
 
 
Net Operating Income
 
 
 
 
 
 
 
 
GAAP income before taxes
 
$
13,005

 
$
9,894

 
$
35,600

 
$
22,286

Add: (loss) gain on sale of securities and impairment
 
(235
)
 
65

 
(231
)
 
171

Add: tax equivalent adjustment
 
1,237

 
1,063

 
3,503

 
2,558

Non-GAAP net operating income before taxes
 
$
14,477

 
$
10,892

 
$
39,334

 
$
24,673

 
 
 
 
 
 
 
 
 
Net Interest Income
 
 
 
 
 
 
 
 
GAAP net interest income
 
$
26,808

 
$
19,674

 
$
74,190

 
$
54,093

Add: tax equivalent adjustment
 
1,059

 
903

 
2,996

 
2,142

Non-GAAP net interest income (fully tax equivalent basis)
 
$
27,867

 
$
20,577

 
$
77,186

 
$
56,235

 
 
 
 
 
 
 
 
 
Core Banking Noninterest Income
 
 
 
 
 
 
 
 
GAAP noninterest income
 
$
5,532

 
$
6,729

 
$
19,044

 
$
18,340

Less: net (loss) gain on securities
 
(235
)
 
65

 
(231
)
 
171

Warrant income
 
721

 
899

 
$
2,937

 
$
3,263

Gain on sale of loans
 
248

 
444

 
750

 
1,665

Bank owned life insurance
 
330

 
298

 
936

 
771

Other
 
137

 
1,607

 
2,573

 
2,739

Non-GAAP core banking noninterest income
 
$
4,331

 
$
3,416

 
$
12,079

 
$
9,731

(1) Does not include a loan servicing asset of $1.3 million and $1.2 million at September 30, 2014 and September 30, 2013, respectively.


44


Executive Overview of Recent Financial Performance
Our strategy is to grow organically in the key U.S. innovation markets. As part of this growth strategy, we expect to evolve our mix of loan business to include more later stage companies and more business with venture capital firms and life sciences companies. We believe this loan mix tilt will help us continue to lower credit costs. Certain elements of our business, such as warrant gains, deposit inflows and to some extent credit quality, can create a degree of quarterly variability to our numbers.
We continued to experience solid balance sheet and revenue growth, which resulted in increased net operating income during the three and nine months ended September 30, 2014. We had net income available to common shareholders of $8.8 million and diluted earnings per share of $0.29 for the three months ended September 30, 2014, compared to net income available to common shareholders of $6.9 million and diluted earnings per share of $0.29 for the three months ended September 30, 2013. Return on average common equity was 12.01% and return on average assets was 1.22% for the three months ended September 30, 2014. Consolidated net income available to common shareholders for the nine months ended September 30, 2014 was $24.6 million, or $0.87 per diluted share, compared to $15.3 million, or $0.64 per diluted share, for the nine months ended September 30, 2013. Return on average common equity was 13.01% and return on average assets was 1.25% for the nine months ended September 30, 2014.
We experienced strong growth in net interest income compared to the three and nine months ended September 30, 2013. Net interest income increased as a result of significant growth in both our loans and deposits. Average loan balances for the three months ended September 30, 2014, were $1.2 billion, compared to $943.7 million for the three months ended September 30, 2013. Average loan balances for the nine months ended September 30, 2014, were $1.1 billion, compared to $872.9 million for the nine months ended September 30, 2013. Period-end loans increased $188.9 million from December 31, 2013. Overall credit quality remains strong. At September 30, 2014, our ratio of nonperforming loans to total loans was 0.93%, improving from 1.34% at December 31, 2013. Loan growth was funded by our continued success in growing our low cost deposits from new and existing venture firms and entrepreneurial companies. Our average client funds, which consist of on-balance sheet deposits and client investment funds, increased $1.1 billion, or 47.8%, and $939.0 million, or 43.0%, respectively, for the three and nine months ended September 30, 2014 compared to the three and nine months ended September 30, 2013. Higher balances and yields on our investment portfolio also drove the increase in net interest income. We also continue to experience favorable funding of our interest earning assets with 65.2% and 64.8%, respectively, of our average deposits for the three and nine months ended September 30, 2014 coming from noninterest-bearing deposits, compared to 59.9% and 61.5%, respectively, for the three and nine months ended September 30, 2013. Net interest margin increased to 4.00% and 4.04%, respectively, for the three and nine months ended September 30, 2014 compared to 3.95% and 3.89%, respectively, for the same periods in the prior year.
Core banking noninterest income within noninterest income was $4.3 million for the three months ended September 30, 2014, an increase of $0.9 million, or 26.8%, compared to the three months ended September 30, 2013. Total noninterest income decreased $1.2 million, or 17.8%, compared to the three months ended September 30, 2013, primarily driven by a $1.2 million decrease in income from our venture capital fund investments due to unrealized losses. The increase in core banking noninterest income was offset by higher net losses on the sale of securities of $0.3 million, lower warrant income of $0.2 million, and lower gains on sales of SBA loans of $0.2 million. Quarterly results from our venture capital fund investments are not indicative of annual results as income from venture capital fund investments can be volatile. Core banking noninterest income was $12.1 million for the nine months ended September 30, 2014, an increase of $2.3 million, or 24.1%, compared to the nine months ended September 30, 2013. Total noninterest income increased $0.7 million, or 3.8%, compared to the nine months ended September 30, 2013, as the $2.3 million increase in core banking noninterest income was largely offset by higher net losses on the sale of securities of $0.4 million, lower warrant income of $0.3 million, and lower gains on sales of SBA loans of $0.9 million.
Noninterest expense increased $3.2 million, or 23.3%, compared to the three months ended September 30, 2013 and increased $8.2 million, or 20.1%, compared to the nine months ended September 30, 2013. As we continue to grow our business and add employees to support our growth, we will continue to incur additional personnel and benefits expenses related to such growth. In addition, our occupancy, data processing and furniture and equipment expenses are increasing in 2014 due to expansion of our loan production offices and banking system updates. Expansion of our loan production offices and system updates have and will continue to result in increased expenses in 2014 and into 2015. Increases in the provision for unfunded credit commitments compared to the three and nine months ended September 30, 2013, also contributed to higher noninterest expense.
On March 31, 2014, we sold a total of 3,125,000 shares of Class A common stock in our initial public offering at an initial public offering price of $18.00 and received net proceeds of $51.1 million after deducting approximately $3.8 million in underwriting discounts and commissions and approximately $1.4 million in IPO-related expenses. We intend to use these

45


proceeds to support our long-term growth by enhancing our capital ratios in light of Basel III, and for general working capital and other corporate purposes. On April 2, 2014, all 5,000 shares of Series A 5% Fixed Rate Cumulative Convertible Preferred Stock were converted by the holder into 500,070 shares of common stock. During the nine months ended September 30, 2014, investors converted $7.4 million of outstanding convertible trust preferred securities into 741,500 common shares. At September 30, 2014, no convertible trust preferred securities remained outstanding.
Critical Accounting Policies and Estimates
Our management's discussion and analysis of financial condition and results of operations is based on our unaudited interim consolidated financial statements, which were prepared in accordance with GAAP. In preparing our unaudited interim consolidated financial statements, we made certain estimates that were critical in nature to our financial condition and results of operations as they require us to make especially difficult, subjective and/or complex judgments about matters that are inherently uncertain and because it is likely that materially different amounts would be reported using different conditions and assumptions. We have discussed the development and selection of these critical accounting policies and estimates with the Audit Committee of our Board of Directors.
There have been no material changes to critical accounting policies and estimates discussed under "Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates" in the Registration Statement.
Impact of Recent Accounting Pronouncements
The information required by this item is included in Note 2 to the consolidated financial statements included in this Form 10-Q.
RESULTS OF OPERATIONS
Performance Summary
Three Months Ended September 30, 2014 and 2013. For the three months ended September 30, 2014, we reported net income available to common shareholders of $8.8 million, an increase of $1.8 million, or 26.7%, compared to net income available to common shareholders of $6.9 million for the three months ended September 30, 2013. The increase resulted from a $7.1 million, or 36.3%, increase in net interest income, partially offset by a $1.2 million, or 17.8%, decrease in noninterest income and a $3.2 million, or 23.3%, increase in noninterest expense.
The increase in net interest income compared to the three months ended September 30, 2013 was primarily the result of our continued success in growing our loan portfolio and low cost deposits, along with higher balances and yields on our investment portfolio. The decrease in noninterest income was primarily due to a $1.2 million decrease in income from our venture capital fund investments due to unrealized losses, higher net losses on the sale of securities of $0.3 million, lower warrant income of $0.2 million, and $0.2 million lower gain on sale of SBA loans due to our strategic decision to hold more SBA loans in our loan portfolio, partially offset by a $0.9 million increase in core banking noninterest income. The increase in noninterest expense compared to the three months ended September 30, 2013 was primarily due to $2.2 million higher personnel expenses in the three months ended September 30, 2014 driven by an increase of 27 full-time equivalent employees and higher incentive compensation expense. Increases in data processing and furniture and equipment expenses also contributed to higher total noninterest expense.
Nine Months Ended September 30, 2014 and 2013. For the nine months ended September 30, 2014, we reported net income available to common shareholders of $24.6 million, an increase of $9.3 million, or 61.2%, compared to net income available to common shareholders of $15.3 million for the nine months ended September 30, 2013. The increase resulted from a $20.1 million, or 37.2%, increase in net interest income and a $0.7 million, or 3.8%, increase in noninterest income, partially offset by a $8.2 million, or 20.1%, increase in noninterest expense.
The increase in net interest income compared to the nine months ended September 30, 2013 was primarily the result of the same factors as in the three months ended September 30, 2014. The increase in noninterest income was primarily due to a $2.3 million increase in core banking noninterest income, which was largely offset by higher net losses on the sale of securities of $0.4 million, lower warrant income of $0.3 million, and lower gain on sale of SBA loans of $0.9 million due to our strategic decision to hold more SBA loans in our loan portfolio. The increase in noninterest expense was largely due to $6.0 million higher personnel expenses driven by the increase in full-time equivalent employees and higher incentive compensation expense, as well as the increases in the provision for unfunded credit commitments and higher data processing and furniture and equipment expenses.

46


Net Interest Income and Net Interest Margin (Fully Tax Equivalent Basis)
The information set forth below contains certain financial information determined by methods other than in accordance with GAAP. See "Non-GAAP Financial Measures" section for a reconciliation of this non-GAAP measure to its most comparable GAAP measure.
Net interest income, the primary contributor to our earnings, represents the difference between the income that we earn on our interest-earning assets and the cost to us of our interest-bearing liabilities. Our net interest income depends upon the volume of interest-earning assets and interest-bearing liabilities and the interest rates that we earn or pay on them. Net interest income is affected by changes in the amount and mix of interest-earning assets and interest-bearing liabilities, referred to as “volume changes.” It is also affected by changes in yields earned on interest-earning assets and rates paid on interest-bearing deposits and other borrowed funds, referred to as “rate changes.” The yield earned on loans includes loan fees, which are primarily loan origination fees and loan documentation fees related to loan origination. Net interest income and the net interest margin are presented on a fully taxable equivalent basis based on the federal statutory rate of 35% to consistently reflect income from taxable loans and securities and tax-exempt securities.
Net Interest Income (Fully Tax Equivalent Basis)
Three Months Ended September 30, 2014 and 2013. For the three months ended September 30, 2014, net interest income increased $7.3 million, or 35.4%, to $27.9 million compared to the three months ended September 30, 2013. This increase was primarily driven by a $7.1 million, or 33.9%, increase in interest income. Our interest income increase primarily resulted from:
a $4.4 million, or 29.3%, increase to $19.3 million in interest income on loans, resulting from a 29.7% higher average balance, partially offset by a 2 basis point decline in the yield earned. The 2 basis point decline in the yield earned resulted from increased competitive pressure in the current low rate environment;
a $2.3 million, or 67.8%, increase to $5.6 million in interest income on taxable securities due to a 43.8% higher average balance and a 28 basis point increase in the yield earned. The higher taxable securities balance was driven by investments purchased as a result of deposit growth, and the higher yield was primarily a result of lower premium amortization on agency mortgage-backed securities resulting from slower prepayments; and
a $0.4 million, or 17.1%, increase to $3.0 million in interest income on nontaxable securities caused by a 13.0% higher average balance and a 17 basis point increase in the yield earned on nontaxable securities. The higher nontaxable securities balance and yield was primarily a result of our continued purchases of higher yielding municipal securities.
Interest expense of $0.2 million represented a 56.6% decrease from the three months ended September 30, 2013, and was primarily driven by the conversion to common stock of the trust preferred securities in the first half of 2014, and lower yields paid on demand deposit and money market accounts.
Nine Months Ended September 30, 2014 and 2013. For the nine months ended September 30, 2014, net interest income increased $21.0 million, or 37.3%, to $77.2 million compared to the nine months ended September 30, 2013. This increase was primarily driven by a $20.6 million, or 36.0%, increase in interest income. Our interest income increase primarily resulted from:
a $11.9 million, or 28.6%, increase to $53.4 million in interest income on loans, resulting from a 30.4% higher average balance, partially offset by a 9 basis point decrease in the yield earned. The 9 basis point decrease in the yield earned resulted from increased competitive pressure in the current low rate environment;
a $6.2 million, or 67.0%, increase to $15.5 million in interest income on taxable securities due to a 34.6% higher average balance and a 39 basis point increase in the yield earned. The higher taxable securities balance was driven by investments purchased as a result of deposit growth, and the higher yield was primarily a result of lower premium amortization on agency mortgage-backed securities resulting from slower prepayments; and
a $2.4 million, or 39.9%, increase to $8.6 million in interest income on nontaxable securities caused by a 29.4% higher average balance and a 37 basis point increase in the yield earned. The higher nontaxable securities balance and yield was primarily a result of our continued purchases of higher yielding municipal securities.
Interest expense of $0.6 million represented a 34.6% decrease from the nine months ended September 30, 2013. This decrease was largely due to the 55.2% decrease in the average balance on junior subordinated debt. Lower yields paid on deposits also contributed to the decrease in interest expense for the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013. Lower yields paid on deposits resulted in a slight decrease in interest expense despite a $144.4 million, or 21.1%, increase in the average balance on interest-bearing deposits.

47


Net Interest Margin (Fully Tax Equivalent Basis)
Three and Nine Months Ended September 30, 2014 and 2013. Our net interest margin increased to 4.00% from 3.95% for the three months ended September 30, 2014 compared to the three months ended September 30, 2013, and increased to 4.04% from 3.89% for the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013. The primary reasons for these increases were:
lower premium amortization on agency mortgage backed securities as loan prepayments slowed;
continued purchasing of higher yielding municipal securities; and
lower cost of funds as interest paid on interest bearing deposits declined and trust preferred securities were converted to common shares.
These increases were partially offset by:
a decline in loan yields in the current low rate environment that continues in 2014.

48


Average Balances and Yields
The following table presents information regarding average balances for assets and liabilities, the total dollar amounts of interest income and dividends from average interest-earning assets, the total dollar amounts of interest expense on average interest-bearing liabilities, and the resulting average yields and costs. The yields and costs for the periods indicated are derived by dividing the income or expense by the average balances for assets or liabilities, respectively, for the periods presented. Loan fees are included in interest income on loans. Yields are presented on a tax equivalent basis.
 
 
Three Months Ended September 30,
 
 
2014
 
2013
 
 
Average
Balance
 
Interest
and
Dividends
 
Yield/
Cost
 
Average
Balance
 
Interest
and
Dividends
 
Yield/
Cost
 
 
(Dollars in thousands)
Interest-earning assets:
 
 
 
 
 
 
 
 
 
 
 
 
Federal Reserve deposits, federal funds sold and other short-term investments
 
$
152,008

 
$
104

 
0.27
%
 
$
111,426

 
$
78

 
0.28
%
Loans, net of unearned income
 
1,223,906

 
19,326

 
6.26

 
943,696

 
14,949

 
6.28

Nontaxable securities
 
248,629

 
3,020

 
4.82

 
220,063

 
2,578

 
4.65

Taxable securities
 
1,137,127

 
5,567

 
1.94

 
790,777

 
3,317

 
1.66

Total interest-earning assets
 
2,761,670

 
28,017

 
4.02

 
2,065,962

 
20,922

 
4.02

Less: Allowance for loan losses
 
(22,888
)
 
 
 
 
 
(18,038
)
 
 
 
 
Noninterest-earning assets
 
99,487

 
 
 
 
 
75,435

 
 
 
 
Total assets
 
$
2,838,269

 
 
 
 
 
$
2,123,359

 
 
 
 
Interest-bearing liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Demand deposits
 
$
87,957

 
18

 
0.08

 
$
92,500

 
33

 
0.14

Money market
 
765,338

 
115

 
0.06

 
641,159

 
131

 
0.08

Time deposits
 
27,997

 
16

 
0.22

 
28,872

 
17

 
0.23

Total interest-bearing deposits
 
881,292

 
149

 
0.07

 
762,531

 
181

 
0.09

FHLB advances
 
543

 

 
0.14

 
4,783

 

 

Repurchase agreements
 

 

 

 
22,525

 
6

 

Junior subordinated debt
 

 
1

 

 
6,205

 
159

 
10.10

Total interest-bearing liabilities
 
881,835

 
150

 
0.07

 
796,044

 
346

 
0.17

Noninterest-bearing deposits
 
1,652,486

 
 
 
 
 
1,138,044

 
 
 
 
Other noninterest-bearing liabilities
 
14,927

 
 
 
 
 
9,313

 
 
 
 
Total liabilities
 
2,549,248

 
 
 
 
 
1,943,401

 
 
 
 
Total shareholders’ equity
 
289,021

 
 
 
 
 
179,958

 
 
 
 
Total liabilities and shareholders’ equity
 
$
2,838,269

 
 
 
 
 
$
2,123,359

 
 
 
 
Net interest income
 
 
 
$
27,867

 
 
 
 
 
$
20,576

 
 
Interest rate spread
 
 
 
 
 
3.95
%
 
 
 
 
 
3.85
%
Net interest margin
 
 
 
 
 
4.00
%
 
 
 
 
 
3.95
%
Ratio of average interest-earning assets to average interest-bearing liabilities
 
 
 
 
 
313.17
%
 
 
 
 
 
259.53
%

49


 
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
 
Average
Balance
 
Interest
and
Dividends
 
Yield/
Cost
 
Average
Balance
 
Interest
and
Dividends
 
Yield/
Cost
 
 
(Dollars in thousands)
Interest-earning assets:
 
 
 
 
 
 
 
 
 
 
 
 
Federal Reserve deposits, federal funds sold and other short-term investments
 
$
155,406

 
$
305

 
0.26
%
 
$
114,901

 
$
233

 
0.27
%
Loans, net of unearned income
 
1,138,097

 
53,448

 
6.28

 
872,873

 
41,575

 
6.37

Nontaxable securities
 
236,695

 
8,566

 
4.84

 
182,921

 
6,121

 
4.47

Taxable securities
 
1,019,894

 
15,511

 
2.03

 
757,579

 
9,287

 
1.64

Total interest-earning assets
 
2,550,092

 
77,830

 
4.08

 
1,928,274

 
57,216

 
3.97

Less: Allowance for loan losses
 
(20,827
)
 
 
 
 
 
(16,503
)
 
 
 
 
Noninterest-earning assets
 
91,419

 
 
 
 
 
81,373

 
 
 
 
Total assets
 
$
2,620,684

 
 
 
 
 
$
1,993,144

 
 
 
 
Interest-bearing liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Demand deposits
 
$
107,276

 
63

 
0.08

 
$
56,008

 
61

 
0.14

Money market
 
692,178

 
314

 
0.06

 
594,153

 
369

 
0.08

Time deposits
 
28,090

 
46

 
0.22

 
32,958

 
46

 
0.19

Total interest-bearing deposits
 
827,544

 
423

 
0.07

 
683,119

 
476

 
0.09

FHLB advances
 
842

 
2

 
0.35

 
9,670

 
24

 
0.34

Repurchase agreements
 
2,009

 
1

 

 
7,592

 
6

 

Junior subordinated debt
 
2,781

 
216

 
10.36

 
6,205

 
475

 
10.24

Total interest-bearing liabilities
 
833,176

 
642

 
0.10

 
706,586

 
981

 
0.19

Noninterest-bearing deposits
 
1,521,635

 
 
 
 
 
1,093,411

 
 
 
 
Other noninterest-bearing liabilities
 
11,470

 
 
 
 
 
11,828

 
 
 
 
Total liabilities
 
2,366,281

 
 
 
 
 
1,811,825

 
 
 
 
Total shareholders’ equity
 
254,403

 
 
 
 
 
181,319

 
 
 
 
Total liabilities and shareholders’ equity
 
$
2,620,684

 
 
 
 
 
$
1,993,144

 
 
 
 
Net interest income
 
 
 
$
77,188

 
 
 
 
 
$
56,235

 
 
Interest rate spread
 
 
 
 
 
3.98
%
 
 
 
 
 
3.78
%
Net interest margin
 
 
 
 
 
4.04
%
 
 
 
 
 
3.89
%
Ratio of average interest-earning assets to average interest-bearing liabilities
 
 
 
 
 
306.07
%
 
 
 
 
 
272.90
%



50


Rate/Volume Analysis
The following table sets forth the effects of changing rates and volumes on our net interest income. The rate column shows the effects attributable to changes in rate (changes in rate multiplied by current volume). The volume column shows the effects attributable to changes in volume (changes in volume multiplied by prior rate). The net column represents the sum of the prior columns. For purposes of this table, changes attributable to changes in both rate and volume that cannot be segregated have been allocated proportionally based on the changes due to rate and the changes due to volume.
 
 
Three Months Ended September 30, 2014
 
 
Compared to
 
 
Three Months Ended September 30, 2013
 
 
Increase (Decrease)
Due to
 
 
 
 
Rate
 
Volume
 
Net
 
 
(Dollars in thousands)
Interest income:
 
 
 
 
 
 
Federal Reserve deposits, federal funds sold and other short-term investments
 
$
5

 
$
21

 
$
26

Loans, net of unearned income
 
(62
)
 
4,439

 
4,377

Nontaxable securities(1)
 
8

 
434

 
442

Taxable securities
 
10

 
2,240

 
2,250

Total interest-earning assets
 
(39
)
 
7,134

 
7,095

Interest expense:
 
 
 
 
 
 
Demand deposits
 
(13
)
 
(2
)
 
(15
)
Money market
 
(42
)
 
26

 
(16
)
Time deposits
 

 
(1
)
 
(1
)
Borrowings
 
(8
)
 
(156
)
 
(164
)
Total interest-bearing liabilities
 
(63
)
 
(133
)
 
(196
)
Change in net interest income
 
$
24

 
$
7,267

 
$
7,291

(1)
Tax equivalent income.
 
 
Nine Months Ended September 30, 2014
 
 
Compared to
 
 
Nine Months Ended September 30, 2013
 
 
Increase (Decrease)
Due to
 
 
 
 
Rate
 
Volume
 
Net
 
 
(Dollars in thousands)
Interest income:
 
 
 
 
 
 
Federal Reserve deposits, federal funds sold and other short-term investments
 
$
(2
)
 
$
74

 
$
72

Loans, net of unearned income
 
(760
)
 
12,633

 
11,873

Nontaxable securities(1)
 
792

 
1,653

 
2,445

Taxable securities
 
1,607

 
4,617

 
6,224

Total interest-earning assets
 
1,637

 
18,977

 
20,614

Interest expense:
 
 
 
 
 
 
Demand deposits
 
(54
)
 
56

 
2

Money market
 
(117
)
 
62

 
(55
)
Time deposits
 
7

 
(7
)
 

Borrowings
 
104

 
(390
)
 
(286
)
Total interest-bearing liabilities
 
(60
)
 
(279
)
 
(339
)
Change in net interest income
 
$
1,697

 
$
19,256

 
$
20,953

(1)
Tax equivalent income.

51


Provision for Loan Losses
We consider a number of factors in determining the required level of our loan reserves and the provision required to achieve what we believe is the appropriate reserve level, including loan growth, credit risk rating trends, nonperforming loan levels, delinquencies, loan portfolio concentrations and economic and market trends. The provision for loan losses represents our determination of the amount necessary to be charged against the current period’s earnings to maintain the allowance for loan losses at a level that we consider adequate in relation to the estimated losses inherent in the loan portfolio.
Three and Nine Months Ended September 30, 2014 and 2013. For the three months ended September 30, 2014, the provision for loan losses was $2.5 million, a decrease of $0.4 million, or 12.3%, compared to the three months ended September 30, 2013. For the nine months ended September 30, 2014, the provision for loan losses was $8.6 million, a decrease of $0.7 million, or 7.8%, compared to the nine months ended September 30, 2013. The lower provision for the three and nine months ended September 30, 2014 reflected an overall improvement in credit quality, partially offset by the growth in our loan portfolio. At September 30, 2014, nonperforming loans totaled $11.8 million, or 0.93%, of total loans compared to $14.5 million, or 1.34%, of total loans, at December 31, 2013, and $13.4 million, or 1.32%, at September 30, 2013. Net loan charge-offs were $1.2 million, or 0.40%, of average loans (annualized) for the three months ended September 30, 2014, compared to net loan charge-offs of $3.0 million, or 1.25%, of average loans (annualized) for the three months ended September 30, 2013. The allowance for loan losses to nonperforming loans at September 30, 2014 was 193.38%, compared to 134.56% at September 30, 2013. See "Management's Discussion and Analysis of Financial Condition and Results of Operations - Risk Management" for a discussion of credit risk and credit quality.
Noninterest Income
Three and Nine Months Ended September 30, 2014 and 2013. The following tables show the components of noninterest income and the related dollar and percentage changes:
 
 
Three Months Ended September 30,
 
Change
 
 
2014
 
2013
 
Dollars
 
Percent
 
 
(Dollars in thousands)
Core banking income:
 
 
 
 
 
 
 
 
Service charges and fees
 
$
1,150

 
$
1,069

 
$
81

 
7.6
 %
Foreign exchange fees
 
1,792

 
1,270

 
522

 
41.1

Credit card and merchant income
 
914

 
605

 
309

 
51.1

Letter of credit fees
 
293

 
271

 
22

 
8.1

Client investment fees(1)
 
79

 
48

 
31

 
64.6

Loan documentation fees(1)
 
103

 
153

 
(50
)
 
(32.7
)
Total core banking noninterest income
 
4,331

 
3,416

 
915

 
26.8

Net (loss) gain on securities
 
(235
)
 
65

 
(300
)
 
(461.5
)
Warrant income
 
721

 
899

 
(178
)
 
(19.8
)
Gain on sale of loans
 
248

 
444

 
(196
)
 
(44.1
)
Bank owned life insurance
 
330

 
298

 
32

 
10.7

Other
 
137

 
1,607

 
(1,470
)
 
(91.5
)
Total noninterest income
 
$
5,532

 
$
6,729

 
$
(1,197
)
 
(17.8
)%
(1) Included in other noninterest income in the consolidated statements of operations.

52


 
 
Nine Months Ended September 30,
 
Change
 
 
2014
 
2013
 
Dollars
 
Percent
 
 
(Dollars in thousands)
Core banking income:
 
 
 
 
 
 
 
 
Service charges and fees
 
$
3,345

 
$
3,020

 
$
325

 
10.8
 %
Foreign exchange fees
 
4,795

 
3,635

 
1,160

 
31.9

Credit card and merchant income
 
2,314

 
1,787

 
527

 
29.5

Letter of credit fees
 
1,104

 
785

 
319

 
40.6

Client investment fees(1)
 
185

 
171

 
14

 
8.2

Loan documentation fees(1)
 
336

 
333

 
3

 
0.9

Total core banking noninterest income
 
12,079

 
9,731

 
2,348

 
24.1

Net (loss) gain on securities
 
(231
)
 
171

 
(402
)
 
(235.1
)
Warrant income
 
2,937

 
3,263

 
(326
)
 
(10.0
)
Gain on sale of loans
 
750

 
1,665

 
(915
)
 
(55.0
)
Bank owned life insurance
 
936

 
771

 
165

 
21.4

Other(1)
 
2,573

 
2,739

 
(166
)
 
(6.1
)
Total noninterest income
 
$
19,044

 
$
18,340

 
$
704

 
3.8
 %
(1) Included in other noninterest income in the consolidated statements of operations.
Core banking noninterest income represents recurring income from traditional banking services provided to our customers. The $0.9 million, or 26.8%, and $2.3 million, or 24.1%, increase in core banking noninterest income for the three and nine months ended September 30, 2014, respectively, was primarily due to an increased customer base combined with increased utilization of our core banking services by our customers. Service charges and fees represent fees earned on our deposit accounts. Foreign exchange fees are primarily transaction-based fees earned from our customers for performing foreign currency-based transactions on their behalf. The increase in foreign exchange fees reflects the expanding geographic footprint of our clients, and our ability to cross-sell our banking services. Additionally, foreign exchange fee income fluctuates based on our customers' needs for foreign currency-based transactions and the three months ended September 30, 2014 reflects certain large transactions, which may not occur in future periods. Credit card and merchant income represents fees earned on credit card accounts and transactions. The increase in credit card and merchant income reflects growth in credit card accounts. Credit card balances outstanding were $19.3 million, $11.6 million and $9.2 million at September 30, 2014, December 31, 2013 and September 30, 2013, respectively. Letters of credit fees represent fees charged to issue and process letters of credit for customers. The increase in letters of credit fees for the nine months ended September 30, 2014 was driven by an increase in the volume of letters of credit. These increases in fees for the three and nine months ended September 30, 2014 are consistent with new customer growth and increased utilization of our core banking services by our existing customers.
For the three and nine months ended September 30, 2014, net loss on the sale of securities includes losses on the sale of equity securities held in our investment portfolio that we obtained in public companies through the exercise of warrants and the decrease in gain on sale of loans was due to our strategic decision to hold more SBA loans in our loan portfolio.
The decrease in our other noninterest income for the three months ended September 30, 2014, compared to the three months ended September 30, 2013, was primarily driven by a $1.2 million decrease in income from our venture capital fund investments due to unrealized losses. Quarterly results from our venture capital fund investments are not indicative of annual results as income from venture capital fund investments can be volatile. See Note 15 for further information regarding our venture capital fund investments.
Warrant income includes income realized upon the exercise of a warrant, as well as unrealized gains and losses from the quarterly mark-to-market of our warrant portfolio. The timing and volume of successful liquidity events, including IPOs, for the clients in which we had taken warrant positions, and changes in the fair value of our equity warrant assets drive variances in warrant income. The variances in warrant income demonstrate the volatility of this income which is created, in part, by the erratic nature of public equity markets and their receptivity to IPOs.



53


The following tables show the components of warrant income and the period-to-period changes (see further discussion of our equity warrant assets in Note 14 to the interim consolidated financial statements):
 
 
Three Months Ended September 30,
 
Change
 
 
2014
 
2013
 
Dollars
 
Percent
 
 
(Dollars in thousands)
Equity warrant assets:
 
 
 
 
 
 
 
 
Net gains on exercise of equity warrant assets
 
$
1,805

 
$
2,433

 
$
(628
)
 
(25.8
)%
Non-monetized write off of warrant assets
 
(178
)
 
(132
)
 
(46
)
 
34.8

Net realized gains on equity warrants
 
1,627

 
2,301

 
(674
)
 
(29.3
)
Change in fair value
 
(906
)
 
(1,402
)
 
496

 
35.4

Warrant income
 
$
721

 
$
899

 
$
(178
)
 
(19.8
)%
 
 
Nine Months Ended September 30,
 
Change
 
 
2014
 
2013
 
Dollars
 
Percent
 
 
(Dollars in thousands)
Equity warrant assets:
 
 
 
 
 
 
 
 
Net gains on exercise of equity warrant assets
 
$
4,821

 
$
4,043

 
$
778

 
19.2
 %
Non-monetized write off of warrant assets
 
(354
)
 
(310
)
 
(44
)
 
14.2

Net realized gains on equity warrants
 
4,467

 
3,733

 
734

 
19.7

Change in fair value
 
(1,530
)
 
(470
)
 
(1,060
)
 
(225.5
)
Warrant income
 
$
2,937

 
$
3,263

 
$
(326
)
 
(10.0
)%
During the three and nine months ended September 30, 2014, our net realized gains were largely driven by public company equity warrants. During the three months ended September 30, 2014, we realized warrant gains in 15 companies, including the exercise of warrants with a total value of $1.4 million for equity securities in six publicly traded companies, of which five companies had conducted IPOs in 2014. During the three months ended September 30, 2014, the Company monetized equity securities for $0.7 million in proceeds following the expiration of their applicable lock-up periods. The equity securities had an initial value of $0.9 million and we recognized a loss of $0.2 million. We had obtained these equity securities through the exercise of warrants in two public companies.
During the nine months ended September 30, 2014 , we realized warrant gains in 48 companies, including the exercise of warrants with a total value of $2.8 million for equity securities in 10 publicly traded companies, of which eight companies had conducted IPOs in 2014. During the nine months ended September 30, 2014, the Company monetized equity securities for $1.0 million in proceeds following the expiration of their applicable lock-up periods. The equity securities had an initial value of $1.2 million and we recognized a loss of $0.2 million. We had obtained these equity securities through the exercise of warrants in three public companies.
During the three and nine months ended September 30, 2013, we realized warrant gains in 9 companies, and 23 companies, respectively, including the monetization of warrants and a realized gain of $1.3 million on the exercise of warrants in one portfolio company client that conducted an IPO. The Company did not have equity securities obtained from the exercise of warrants in our available for sale portfolio in 2013.




54


Noninterest Expense
Three and Nine Months Ended September 30, 2014 and 2013. The following table shows the components of noninterest expense and the related dollar and percentage changes:
 
 
Three Months Ended September 30,
 
Change
 
 
2014
 
2013
 
Dollars
 
Percent
 
 
(Dollars in thousands)
Personnel
 
$
10,790

 
$
8,639

 
$
2,151

 
24.9
 %
Occupancy
 
713

 
691

 
22

 
3.2

Data processing
 
1,090

 
897

 
193

 
21.5

Furniture and equipment
 
769

 
589

 
180

 
30.6

Advertising and promotions
 
223

 
267

 
(44
)
 
(16.5
)
Professional fees
 
976

 
876

 
100

 
11.4

Telecommunications
 
246

 
283

 
(37
)
 
(13.1
)
Travel
 
259

 
211

 
48

 
22.7

FDIC assessment
 
393

 
349

 
44

 
12.6

Other
 
1,376

 
857

 
519

 
60.6

Total noninterest expense
 
$
16,835

 
$
13,659

 
$
3,176

 
23.3
 %
 
 
Nine Months Ended September 30,
 
Change
 
 
2014
 
2013
 
Dollars
 
Percent
 
 
(Dollars in thousands)
Personnel
 
32,148

 
$
26,128

 
$
6,020

 
23.0
 %
Occupancy
 
2,227

 
2,082

 
145

 
7.0

Data processing
 
2,830

 
2,229

 
601

 
27.0

Furniture and equipment
 
2,131

 
1,850

 
281

 
15.2

Advertising and promotions
 
840

 
891

 
(51
)
 
(5.7
)
Professional fees
 
2,363

 
2,280

 
83

 
3.6

Telecommunications
 
791

 
866

 
(75
)
 
(8.7
)
Travel
 
717

 
762

 
(45
)
 
(5.9
)
FDIC assessment
 
1,145

 
949

 
196

 
20.7

Other
 
3,826

 
2,768

 
1,058

 
38.2

Total noninterest expense
 
$
49,018

 
$
40,805

 
$
8,213

 
20.1
 %
Personnel represented 64.1% of our total noninterest expense and increased $2.2 million, or 24.9%, for the three months ended September 30, 2014, and 65.6% of our total noninterest expense and increased $6.0 million, or 23.0%, for the nine months ended September 30, 2014. The increase in personnel expense primarily resulted from an increase in our full-time equivalent employees to 253 at September 30, 2014, from 226 at September 30, 2013, to drive and support our balance sheet and income growth. Over the past year we have added 18 venture bankers and client managers in key markets, including Menlo Park, San Francisco, San Diego, Los Angeles, Orange County and Campbell, CA, and Boston, Chicago and New York. Additionally, our acquisition of Sand Hill Finance on December 31, 2013 yielded seven additional employees. In addition, our occupancy and furniture and equipment expenses are increasing in 2014 due to our assumption of the leases for the Sand Hill Finance LLC offices, the addition of new loan production offices in San Francisco which opened in the second quarter, and Chicago which is expected to open later in 2014, and an increase in our lease expenses for one of our existing loan production offices. Data processing fees have also increased to support our overall growth in connection with upgrades for our lending and credit operations. These updates have and will continue to result in increased expenses in 2014. Higher other noninterest expense was primarily driven by an increase in the provision for unfunded credit commitments.

55


Income Tax Provision
Three and Nine Months Ended September 30, 2014 and 2013. Income tax expense increased $1.3 million, or 45.4%, for the three months ended September 30, 2014 as compared to the same period in the prior year, primarily due to a $3.1 million, or 31.4%, increase in pre-tax income. Income tax expense increased $4.1 million, or 60.0%, for the nine months ended September 30, 2014 as compared to the same period in the prior year, primarily due to a $13.3 million, or 59.7%, increase in pre-tax income. Our effective tax rate increased to 32.7% for the three months ended September 30, 2014 from 29.6% for the three months ended September 30, 2013, and to 30.8% for the nine months ended September 30, 2014 from 30.7% for the nine months ended September 30, 2013, as a result of the tax impact of the one-time gain recorded on the transfer of the contract for the management of Square 1 Venture 1, L.P. to a third party and a decrease in our tax preferred income from our municipal securities portfolio.
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
Our total assets increased $661.8 million, or 28.4%, to $3.0 billion at September 30, 2014, from $2.3 billion at December 31, 2013, primarily due to deposit growth of $561.7 million and the proceeds of our initial public offering of $51.1 million, which resulted in $79.9 million in additional period end cash and cash equivalents, a $386.5 million increase in our investment securities portfolio, and a $188.9 million increase in our loan portfolio.
Our deposit and loan portfolios include entrepreneurial companies at all stages of their life cycles, as well as venture firms. The following table provides a summary of total loans outstanding, total unfunded loan commitments and deposit balances by stage and type at September 30, 2014 and December 31, 2013:
 
 
September 30, 2014
 
 
 
Loans Outstanding
 
 
Unfunded Loan
Commitments
 
 
Deposit Balances
 
 
 
Amount
 
Percent
 
 
Amount
 
Percent
 
 
Amount
 
Percent
 
 
 
(Dollars in thousands)
 
Stage:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Early
 
$
202,154

 
15.81
%
 
$
110,260

 
9.45
%
 
$
1,250,453

 
46.86
%
Expansion
 
603,802

 
47.22
 
 
337,667

 
28.93
 
 
588,717

 
22.06
 
Late
 
227,077

 
17.76
 
 
171,920

 
14.73
 
 
380,833

 
14.27
 
Total portfolio company
 
1,033,033

 
80.79
 
 
619,847

 
53.11
 
 
2,220,003

 
83.19
 
Venture capital/private equity
 
159,349

 
12.46
 
 
519,552

 
44.52
 
 
448,025

 
16.79
 
SBA and USDA
 
67,067

 
5.24
 
 
5,059

 
0.43
 
 
417

 
0.02
 
Credit cards
 
19,345

 
1.51
 
 
22,657

 
1.94
 
 

 
 
Total
 
1,278,794

 
100.00
%
 
$
1,167,115

 
100.00
%
 
$
2,668,445

 
100.00
%
Less unearned income
 
(7,337
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total loans, net of unearned income
 
$
1,271,457

 
 
 
 
 
 
 
 
 
 
 
 
 

56


 
 
December 31, 2013
 
 
 
Loans Outstanding
 
 
Unfunded Loan
Commitments
 
 
Deposit Balances
 
 
 
Amount
 
Percent
 
 
Amount
 
Percent
 
 
Amount
 
Percent
 
 
 
(Dollars in thousands)
 
Stage:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Early
 
$
146,096

 
13.44
%
 
$
81,611

 
8.35
%
 
$
730,511

 
34.67
%
Expansion
 
590,511

 
54.32
 
 
299,898

 
30.69
 
 
746,032

 
35.41
 
Late
 
143,925

 
13.24
 
 
163,231

 
16.70
 
 
223,989

 
10.63
 
Total portfolio company
 
880,532

 
81.00
 
 
544,740

 
55.74
 
 
1,700,532

 
80.71
 
Venture capital/private equity
 
143,468

 
13.20
 
 
415,830

 
42.55
 
 
405,870

 
19.27
 
SBA and USDA
 
51,510

 
4.74
 
 
2,388

 
0.25
 
 
325

 
0.02
 
Credit cards
 
11,575

 
1.06
 
 
14,304

 
1.46
 
 

 
 
Total
 
1,087,085

 
100.00
%
 
$
977,262

 
100.00
%
 
$
2,106,727

 
100.00
%
Less unearned income
 
(4,549
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total loans, net of unearned income
 
$
1,082,536

 
 
 
 
 
 
 
 
 
 
 
 
 
Loans
The following table presents the loan balances and associated percentage of each category of loans within our loan portfolio at the dates indicated:
 
 
September 30, 2014
 
December 31, 2013
 
 
Amount
 
Percent
 
Amount
 
Percent
 
 
(Dollars in thousands)
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
634,908

 
49.65
%
 
$
543,788

 
50.02
%
Life sciences
 
240,375

 
18.80

 
224,069

 
20.61

Asset-based loans
 
152,282

 
11.91

 
111,251

 
10.24

Venture capital/private equity
 
159,349

 
12.46

 
143,468

 
13.20

SBA and USDA
 
33,245

 
2.60

 
23,719

 
2.18

Other
 
5,468

 
0.42

 
1,424

 
0.13

Total commercial loans
 
1,225,627

 
95.84

 
1,047,719

 
96.38

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 
31,532

 
2.47

 
27,504

 
2.53

Total real estate loans
 
31,532

 
2.47

 
27,504

 
2.53

Construction:
 
 
 
 
 
 
 
 
SBA and USDA
 
2,290

 
0.18

 
287

 
0.03

Total construction loans
 
2,290

 
0.18

 
287

 
0.03

Credit cards
 
19,345

 
1.51

 
11,575

 
1.06

Total loans
 
1,278,794

 
100.00
%
 
1,087,085

 
100.00
%
Less unearned income(1)
 
(7,337
)
 
 
 
(4,549
)
 
 
Total loans, net of unearned income
 
$
1,271,457

 


 
$
1,082,536

 
 
(1)
Unearned income consists of unearned loan fees, the discount on SBA loans and the unearned initial warrant value.
The 17.0% increase in commercial loans from December 31, 2013 to September 30, 2014 was primarily driven by increases in total loans to venture-backed companies and the venture firm client industry segment. Within our commercial loan portfolio, our loans to venture firm clients fluctuate from period-to-period based on funding needs driven by investment cycles and timing. The amount of loan commitments that are utilized by these clients vary during the year and often increase at the end of the year when these clients may increase the amount drawn on their lines of credit for various business reasons. Growth

57


in SBA and USDA loans also contributed to the overall growth in commercial loans from December 31, 2013 to September 30, 2014.
Total loans to venture-backed companies were up $148.5 million, or 16.9%, while loans to venture firms increased $15.9 million, or 11.1%, at September 30, 2014 compared to December 31, 2013. Our asset-based loans to venture-backed companies increased $41.0 million, or 36.9%, from December 31, 2013 to September 30, 2014. This increase in our asset-based loans was primarily due to our strategic focus on expanding this product line to better serve the needs of our expansion and late stage clients.
We began offering SBA and USDA loans in 2011. At September 30, 2014, SBA and USDA loans represented 5.2% of our loan portfolio compared to 4.7% at December 31, 2013. Total SBA and USDA loans increased $15.6 million, or 30.2%, from December 31, 2013 to September 30, 2014. We expect to continue to grow our SBA and USDA loan portfolio as we originate new loans and sell a portion of the guaranteed balances. We also made a strategic decision to hold more SBA loans in our loan portfolio.
Loan Concentration
Loan concentrations may exist when there are borrowers engaged in similar activities or types of loans extended to a diverse group of borrowers that could cause those borrowers or portfolios to be similarly impacted by economic or other conditions.
The breakdown of total loans by industry sector at September 30, 2014 and December 31, 2013, is as follows:
 
 
September 30, 2014
 
December 31, 2013
 
 
Amount
 
Percent
 
Amount
 
Percent
 
 
(Dollars in thousands)
Venture portfolio industry:
 
 
 
 
 
 
 
 
Software
 
$
172,898

 
13.60
 %
 
$
178,408

 
16.47
 %
Business products and services
 
121,033

 
9.52

 
56,635

 
5.23

Hardware
 
112,748

 
8.87

 
76,203

 
7.04

Consumer products and services
 
98,896

 
7.78

 
55,985

 
5.17

Media and telecom
 
91,796

 
7.22

 
70,470

 
6.51

Biotech
 
91,760

 
7.22

 
55,180

 
5.10

Healthcare services
 
79,534

 
6.26

 
75,311

 
6.96

IT services
 
65,520

 
5.15

 
68,203

 
6.30

Medical devices and equipment
 
56,755

 
4.46

 
57,725

 
5.33

Financial services
 
39,400

 
3.10

 
55,215

 
5.10

Other industries
 
102,764

 
8.08

 
131,332

 
12.13

Total venture portfolio industry
 
1,033,104

 
81.26

 
880,667

 
81.34

VCS
 
159,349

 
12.53

 
143,468

 
13.25

SBA and USDA
 
67,067

 
5.28

 
51,510

 
4.76

Credit cards
 
19,345

 
1.52

 
11,575

 
1.08

Other (overdrafts and in-process)
 
(71
)
 
(0.01
)
 
(135
)
 
(0.01
)
Total loans
 
1,278,794

 
100.58

 
1,087,085

 
100.42

Less unearned income
 
(7,337
)
 
(0.58
)
 
(4,549
)
 
(0.42
)
Loans, net of unearned income
 
$
1,271,457

 
100.00
 %
 
$
1,082,536

 
100.00
 %

58


The following table provides a summary of total loans by size and category. The breakout of the categories is based on total client balances (individually or in the aggregate) at September 30, 2014 and December 31, 2013:
 
 
September 30, 2014
 
 
Total
 
Less than $5 Million
 
$5 Million - $10 Million
 
Greater than $10 Million
 
 
Amount
 
Number
 
Amount
 
Number
 
Amount  
 
Number  
 
Amount  
 
Number  
 
 
(Dollars in thousands)
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$
634,908

 
259

 
$
357,825

 
225

 
$
182,610

 
27

 
$
94,473

 
7

Life sciences
 
240,375

 
73

 
105,070

 
57

 
75,196

 
12

 
60,109

 
4

Asset-based loans
 
152,282

 
74

 
38,325

 
64

 
35,935

 
5

 
78,022

 
5

Venture capital/private equity
 
159,349

 
62

 
53,877

 
53

 
25,797

 
4

 
79,675

 
5

SBA and USDA
 
33,245

 
55

 
33,245

 
55

 

 

 

 

Other
 
5,468

 
11

 
5,468

 
11

 

 

 

 

Total commercial loans
 
1,225,627

 
534

 
593,810

 
465

 
319,538

 
48

 
312,279

 
21

Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
31,532

 
53

 
25,659

 
52

 
5,873

 
1

 

 

Total real estate loans
 
31,532

 
53

 
25,659

 
52

 
5,873

 
1

 

 

Construction loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
2,290

 
4

 
2,290

 
4

 

 

 

 

Total construction loans
 
2,290

 
4

 
2,290

 
4

 

 

 

 

Credit cards
 
19,345

 
498

 
19,345

 
498

 

 

 

 

Total loans
 
1,278,794

 
1,089

 
$
641,104

 
1,019

 
$
325,411

 
49

 
$
312,279

 
21

Less unearned income
 
(7,337
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loans, net of unearned income
 
$
1,271,457

 
 
 
 
 
 
 
 
 
 
 
 
 
 


59


 
 
December 31, 2013
 
 
Total
 
Less than $5 Million
 
$5 Million - $10 Million
 
Greater than $10 Million
 
 
Amount
 
Number
 
Amount
 
Number
 
Amount  
 
Number  
 
Amount  
 
Number  
 
 
(Dollars in thousands)
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$
543,788

 
248

 
$
341,433

 
220

 
$
185,189

 
27

 
$
17,166

 
1

Life sciences
 
224,069

 
70

 
98,910

 
56

 
67,259

 
10

 
57,900

 
4

Asset-based loans
 
111,251

 
58

 
43,494

 
53

 
9,217

 
1

 
58,540

 
4

Venture firm
 
143,468

 
70

 
60,168

 
61

 
40,496

 
6

 
42,804

 
3

SBA and USDA
 
23,719

 
40

 
23,719

 
40

 

 

 

 

Other
 
1,424

 
18

 
1,424

 
18

 

 

 

 

Total commercial loans
 
1,047,719

 
504

 
569,148

 
448

 
302,161

 
44

 
176,410

 
12

Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
27,504

 
44

 
21,669

 
43

 
5,835

 
1

 

 

Total real estate loans
 
27,504

 
44

 
21,669

 
43

 
5,835

 
1

 

 

Construction loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
287

 
1

 
287

 
1

 

 

 

 

Total construction loans
 
287

 
1

 
287

 
1

 

 

 

 

Credit cards
 
11,575

 
578

 
11,575

 
578

 

 

 

 

Total loans
 
1,087,085

 
1,127

 
$
602,679

 
1,070

 
$
307,996

 
45

 
$
176,410

 
12

Less unearned income
 
(4,549
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loans, net of unearned income
 
$
1,082,536

 
 
 
 
 
 
 
 
 
 
 
 
 
 

Loan Maturity
At September 30, 2014, 91.3%, or $1.2 billion, of our total outstanding gross loans were variable rate loans that adjust at specified dates based on our prime lending rate or other variable indices, compared to 92.7%, or $1.0 billion, at December 31, 2013. At September 30, 2014, just over 48% of the loans had floors above the floating rate coupon. After an increase in rates of 100 bps, only 9% of these loans will continue to have floors above the floating rate coupon.

60


The following table sets forth the remaining contractual maturity distribution of our gross loan portfolio, by industry sector, at September 30, 2014 and December 31, 2013, for fixed and variable rate loans:
 
 
September 30, 2014
 
 
Remaining Contractual Maturity of Gross Loans
 
 
One Year
or Less
 
After One
Year and
Through
Five Years
 
After
Five Years
 
Total
 
 
(In thousands)
Fixed-rate loans:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
8,401

 
$
9,564

 
$

 
$
17,965

Life sciences
 
6,020

 
58,477

 

 
64,497

Asset-based loans
 
22,103

 
1,362

 

 
23,465

Venture capital/private equity
 

 
366

 

 
366

SBA and USDA
 

 

 
1,176

 
1,176

Other
 

 

 
3,778

 
3,778

Total commercial loans
 
36,524

 
69,769

 
4,954

 
111,247

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 
491

 
491

Total real estate loans
 

 

 
491

 
491

Total construction loans
 

 

 

 

Credit cards
 

 

 

 

Total fixed-rate loans
 
$
36,524

 
$
69,769

 
$
5,445

 
$
111,738

Variable-rate loans:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
270,014

 
$
346,929

 
$

 
$
616,943

Life sciences
 
74,463

 
101,415

 

 
175,878

Asset-based loans
 
66,791

 
62,026

 

 
128,817

Venture capital/private equity
 
141,964

 
14,670

 
2,349

 
158,983

SBA and USDA
 

 
89

 
31,980

 
32,069

Other
 
1,690

 

 

 
1,690

Total commercial loans
 
554,922

 
525,129

 
34,329

 
1,114,380

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 

 
38

 
31,003

 
31,041

Total real estate loans
 

 
38

 
31,003

 
31,041

Construction loans:
 


 


 


 


SBA and USDA
 

 

 
2,290

 
2,290

Total construction loans
 

 

 
2,290

 
2,290

Credit cards
 
19,345

 

 

 
19,345

Total variable rate loans
 
$
574,267

 
$
525,167

 
$
67,622

 
1,167,056

Less unearned income
 
 
 
 
 
 
 
(7,337
)
Total loans, net of unearned income
 
 
 
 
 
 
 
$
1,271,457


61


 
 
December 31, 2013
 
 
Remaining Contractual Maturity of Gross Loans
 
 
One Year
or Less
 
After One
Year and
Through
Five Years
 
After
Five Years
 
Total
 
 
(In thousands)
Fixed-rate loans:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
1,948

 
$
4,414

 
$

 
$
6,362

Life sciences
 
6,273

 
26,343

 

 
32,616

Asset-based loans
 
19,217

 
18,646

 

 
37,863

Venture capital/private equity
 

 
452

 

 
452

SBA and USDA
 

 

 

 

Other
 

 

 
528

 
528

Total commercial loans
 
27,438

 
49,855

 
528

 
77,821

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 
1,900

 
1,900

Total real estate loans
 

 

 
1,900

 
1,900

Construction
 

 

 

 

Credit cards
 

 

 

 

Total fixed-rate loans
 
$
27,438

 
$
49,855

 
$
2,428

 
$
79,721

Variable-rate loans:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Technology
 
$
219,877

 
$
317,549

 
$

 
$
537,426

Life sciences
 
39,117

 
152,336

 

 
191,453

Asset-based loans
 
50,930

 
22,458

 

 
73,388

Venture capital/private equity
 
121,760

 
19,547

 
1,709

 
143,016

SBA and USDA
 

 

 
23,719

 
23,719

Other
 
896

 

 

 
896

Total commercial loans
 
432,580

 
511,890

 
25,428

 
969,898

Real estate loans:
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 
25,604

 
25,604

Total real estate loans
 

 

 
25,604

 
25,604

Construction loans:
 
 
 
 
 
 
 
 
SBA and USDA
 

 

 
287

 
287

Total construction loans
 

 

 
287

 
287

Credit cards
 
11,575

 

 

 
11,575

Total variable rate loans
 
$
444,155

 
$
511,890

 
$
51,319

 
1,007,364

Less unearned income
 
 
 
 
 
 
 
(4,549
)
Total loans, net of unearned income
 
 
 
 
 
 
 
$
1,082,536

Upon maturity, loans satisfying our credit quality standards may be renewed. Renewals are subject to the same underwriting and credit administration practices as we utilize for new loans. It is not our practice to grant loans with unconditional extension or renewal terms.
Investment Securities
Investment securities totaled $1.5 billion at September 30, 2014, an increase of $386.5 million, or 35.8%, compared to $1.1 billion at December 31, 2013. See Notes 3 and 15 to the unaudited interim consolidated financial statements.

62


Our investment securities portfolio is comprised of both available-for-sale securities and securities that we intend to hold to maturity. We purchase securities for our investment securities portfolio to manage interest rate risk, ensure a stable source of liquidity, and to provide a steady source of income in excess of our cost of funds.
Our available-for-sale securities portfolio totaled $1.2 billion at September 30, 2014, an increase of $262.7 million, or 28.4%, compared to $924.2 million at December 31, 2013. The increase was primarily due to purchases of new investment securities, consisting mostly of agency and non-agency mortgage backed securities and other asset backed securities.
Our held to maturity securities portfolio is mainly comprised of municipal bonds, which we began purchasing for this portfolio in 2011. Prior to that, our held to maturity securities portfolio was primarily comprised of agency mortgage-backed securities. Our held to maturity securities portfolio had an amortized cost of $278.1 million at September 30, 2014, an increase of $123.9 million, or 80.3%, compared to $154.3 million at December 31, 2013. The increase in this portfolio was primarily due to our purchase of new municipal bond securities and agency mortgage backed securities that we intend to hold until they are either called or reach maturity.
At September 30, 2014, the duration of our available-for-sale securities portfolio was approximately 2.1 years and the overall investment securities portfolio duration was 2.7 years.
The following table sets forth the stated maturities and weighted average yields of investment securities at September 30, 2014. Weighted average yields on tax-exempt securities are presented on a tax equivalent basis. While not reflected in the table below, 33.0% of the investment portfolio is either floating rate or adjustable rate securities and will reprice either immediately or within the first year based on the repricing of the underlying loans.
 
 
 
 
September 30, 2014
 
 
 
 
Less than One Year
 
After One to Five Years
 
After Five to Ten Years
 
After Ten Years
 
 
Total
Amortized
Cost
 
Amortized
Cost
 
Average
Yield
 
Amortized
Cost
 
Average
Yield
 
Amortized
Cost
 
Average
Yield
 
Amortized
Cost
 
Average
Yield
 
 
(Dollars in thousands)
Available-for sale-securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasuries
 
$
19,679

 
$

 


 
$
19,679

 
1.29
%
 
$

 


 
$

 


Agency direct obligations
 
34,534

 
3,890

 
2.75

 
30,644

 
0.76

 

 


 

 


SBA pools
 
143,110

 

 


 
5,200

 
1.63

 
60,428

 
1.63

 
77,482

 
1.63

Agency mortgage-backed securities
 
577,389

 

 


 
1,856

 
0.70

 
35,356

 
1.46

 
540,177

 
2.29

Municipal bonds
 
116,840

 

 


 
55,687

 
1.57

 
12,950

 
1.33

 
48,203

 
2.49

Corporates
 
96,402

 

 


 

 


 
12,016

 
3.66

 
84,386

 
4.39

Non-agency mortgage-backed securities
 
132,909

 

 


 
1,495

 
3.62

 
15,316

 
3.39

 
116,098

 
2.52

Other asset-backed securities
 
49,574

 
12,999

 
2.71

 
15,831

 
2.21

 
15,277

 
2.90

 
5,467

 
1.11

Equity securities
 
2,764

 

 


 

 


 

 


 
2,764

 

Total available for sale securities
 
$
1,173,201

 
$
16,889

 
2.72
%
 
$
130,392

 
1.43
%
 
$
151,343

 
2.03
%
 
$
874,577

 
2.46
%
Held-to-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contractual maturity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency mortgage-backed securities
 
$
60,663

 
$

 


 
$

 


 
$

 


 
$
60,663

 
3.17
%
Municipal bonds
 
165,531

 

 


 

 


 
7,460

 
2.59

 
158,071

 
5.45

Corporates
 
51,927

 

 


 

 


 

 


 
51,927

 
4.28

Total held-to-maturity
 
$
278,121

 
$

 
%
 
$

 


 
$
7,460

 
2.59
%
 
$
270,661

 
4.71
%
Total securities
 
$
1,451,322

 
$
16,889

 
2.72
%
 
$
130,392

 
1.43
%
 
$
158,803

 
2.06
%
 
$
1,145,238

 
2.99
%

63


Derivatives
Derivative instruments are recorded as a component of other assets and other liabilities on the balance sheet.
Equity Warrant Assets. In most cases, we seek equity warrants in connection with extending loan commitments to our customers. In general, the equity warrants entitle us to purchase a specific number of shares of a client’s stock at a specific price over a specified time period. The warrants may also include contingent provisions which provide for additional shares to be purchased at a specific price if defined future events occur, such as future rounds of equity financing by the client, or additional borrowings by the client. These warrants are obtained at the inception of a loan facility or the amendment of a loan facility. These warrants are not obtained in lieu of other fees, interest or payments. These warrants potentially provide an additional return, in addition to the traditional loan yield from interest and fees, in the event of a liquidity event of the borrowing company. The grant date fair values of equity warrants received in connection with extending loan commitments are considered to be loan fees and are recognized over the life of the loan commitment as an adjustment to the loan yield through loan interest income. Any changes from the grant date in the fair value of equity warrant assets are recognized as increases or decreases to warrant valuation and as net gains or losses in noninterest income during the period in which the change is recognized. These changes in warrant valuation and related gains or losses may occur as a result of a change in the Black Scholes value of the warrant, or when a portfolio company completes an initial public offering on a publicly reported market or is acquired. We may exercise these equity warrant assets for either shares or cash. When a private company goes public there is often a lock-up period requiring us to hold our equity position in a publicly traded security until the expiration of the lock-up period. Shares received from the exercise of warrants and subject to lock-up agreements are held as equity securities in our available for sale portfolio.
Our equity warrants portfolio is primarily comprised of warrants in non-public companies and our practice generally is to monetize our positions as soon as a liquidity event occurs. Often there is a lock-up period requiring us to hold our equity position in a publicly traded security until the expiration of the lock-up period. Warrants held, which amounted to $4.1 million and $5.1 million in 451 and 451 companies at September 30, 2014 and December 31, 2013, respectively, are shown as warrant valuation in the accompanying consolidated balance sheets. At September 30, 2014, the $4.1 million valuation on warrants held included $0.1 million in equity securities of five publicly traded companies, which we intend to monetize upon removal of all sale restriction for those securities, compared to $1.0 million held in equity securities of three publicly traded companies at December 31, 2013.
During the three and nine months ended September 30, 2014, the Company exercised warrants with a total value of $1.4 million and $2.8 million, respectively, and received equity securities in six and 10 publicly traded companies, respectively. The Company sold a portion of these securities during the three and nine months ended September 30, 2014 (see discussion under "Results of Operations - Noninterest Income"). At September 30, 2014, the fair value of equity securities included in equity securities within our available-for-sale investments obtained through the exercise of warrants and still held was $1.3 million (see Note 3). The Company did not have equity securities obtained from the exercise of warrants in our available for sale portfolio in 2013. See Notes 14 and 15 for further information regarding our equity warrant assets.
Foreign Exchange Forward Contracts. We enter into foreign exchange forward contracts with clients involved in foreign activities, either as the purchaser or seller, depending upon the clients’ needs. For each forward contract entered into with our clients, we enter into an opposite way forward contract with a correspondent bank, which mitigates the risk of fluctuations in currency rates. At September 30, 2014, we had $9.8 million in gross notional customer outstanding forward contracts and an offsetting $9.7 million in gross national correspondent bank outstanding forward contracts. At December 31, 2013, we had $3.9 million in gross notional customer outstanding forward contracts and an offsetting $3.8 million in gross national correspondent bank outstanding forward contracts.


64


Deposits
The following table sets forth the composition of our deposits at September 30, 2014 and December 31, 2013:
 
 
September 30, 2014
 
December 31, 2013
 
 
Amount
 
Percent
 
Amount
 
Percent
 
 
(Dollars in thousands)
Period-end:
 
 
 
 
 
 
 
 
Noninterest-bearing demand deposits
 
$
1,712,674

 
64.18
%
 
$
1,380,024

 
65.51
%
Interest-bearing deposits:
 
 
 
 
 
 
 
 
Demand deposits
 
164,859

 
6.18

 
103,638

 
4.92

Money market
 
774,405

 
29.02

 
596,247

 
28.30

Time deposits
 
16,507

 
0.62

 
26,818

 
1.27

Total period end deposits
 
$
2,668,445

 
100.00
%
 
$
2,106,727

 
100.00
%
The following tables set forth the composition of our average deposits for the three and nine months ended September 30, 2014 and 2013:
 
 
Three Months Ended September 30,
 
 
2014
 
2013
 
 
Amount
 
Percent
 
Amount
 
Percent
 
 
(Dollars in thousands)
Average:
 
 
 
 
 
 
 
 
Noninterest-bearing demand deposits
 
$
1,652,486

 
65.22
%
 
$
1,138,044

 
59.87
%
Interest-bearing deposits:
 
 
 
 
 
 
 
 
Demand deposits
 
87,957

 
3.47

 
92,500

 
4.87

Money market
 
765,338

 
30.21

 
641,159

 
33.74

Time deposits
 
27,997

 
1.10

 
28,872

 
1.52

Total average deposits
 
$
2,533,778

 
100.00
%
 
$
1,900,575

 
100.00
%
 
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
 
Amount
 
Percent
 
Amount
 
Percent
 
 
(Dollars in thousands)
Average:
 
 
 
 
 
 
 
 
Noninterest-bearing demand deposits
 
$
1,521,635

 
64.77
%
 
$
1,093,411

 
61.55
%
Interest-bearing deposits:
 
 
 
 
 
 
 
 
Demand deposits
 
107,276

 
4.57

 
56,008

 
3.15

Money market
 
692,178

 
29.46

 
594,153

 
33.44

Time deposits
 
28,090

 
1.20

 
32,958

 
1.86

Total average deposits
 
$
2,349,179

 
100.00
%
 
$
1,776,530

 
100.00
%
Our deposits increased to $2.7 billion at September 30, 2014, from $2.1 billion at December 31, 2013, an increase of $561.7 million, or 26.7%. This increase was primarily due to growth of our client base and a continued strong funding environment for venture-backed firms. Our noninterest-bearing deposits increased $332.7 million, or 24.1%, and our interest-bearing deposits increased $229.1 million, or 31.5%, during the period.
At September 30, 2014, the aggregate balance of time deposit accounts individually equal to or greater than $100,000 totaled $16.2 million. At September 30, 2014, substantially all time deposit accounts in amounts equal to or greater than $100,000 were scheduled to mature within one year.

65


Client Investment Funds
We utilize alternative cash investment vehicles to manage our on-balance sheet deposit growth, which tends to be volatile as is typical in the market in which we operate. For example, we offer our clients alternative cash investment vehicles such as sweep accounts and investments in the CDARS, the latter of which allows us to place client deposits in one or more insured depository institutions. Square 1 Asset Management offers customized solutions to our clients that are tailored to meet the unique corporate cash management needs of entrepreneurial companies and venture firms. At September 30, 2014 and December 31, 2013, Square 1 Asset Management had $609.3 million and $108.1 million, respectively, of assets under management. We expect to continue to manage our on-balance sheet deposit growth through these alternative investment vehicles for our clients and to grow the amount of assets under management by Square 1 Asset Management.
The following table sets forth the composition of our client investment funds at September 30, 2014 and December 31, 2013:
 
 
September 30, 2014
 
December 31, 2013
 
%
Change
Period-end:
 
(Dollars in thousands)
Client investment assets under management
 
$
609,284

 
$
108,105

 
463.6
 %
Sweep money market funds
 
241,274

 
271,823

 
(11.2
)
CDARS
 
107,076

 
177,955

 
(39.8
)
Total period-end client investment funds
 
$
957,634

 
$
557,883

 
71.7
 %
N/M = Not meaningful
The following tables set forth the composition of average client investment funds for the three and nine months ended September 30, 2014 and 2013:
 
 
Three Months Ended September 30,
 
 
2014
 
2013
 
%
Change
Average:
 
(Dollars in thousands)
Client investment assets under management
 
$
483,147

 
$
6,815

 
6,989.5
 %
Sweep money market funds
 
254,456

 
219,907

 
15.7

CDARS
 
194,177

 
216,890

 
(10.5
)
Total average client investment funds
 
$
931,780

 
$
443,612

 
110.0
 %
 
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
%
Change
Average:
 
(Dollars in thousands)
Client investment assets under management
 
$
280,181

 
$
2,297

 
12,097.7
%
Sweep money market funds
 
288,616

 
214,694

 
34.4

CDARS
 
202,908

 
188,321

 
7.7

Total average client investment funds
 
$
771,705

 
$
405,312

 
90.4
%
N/M = Not meaningful
Repurchase Agreements and Borrowings
As a result of strong deposit growth and proceeds from the initial public offering of our common stock, we decreased borrowings by $18.9 million at September 30, 2014. Repurchase agreements decreased $12.7 million as the result of customer repurchase agreements moving to Square 1 Asset Management, and the remaining $6.2 million balance of subordinated debentures, including respective remaining debt discount, was redeemed as $7.4 million in trust preferred securities were converted to common shares during the nine months ended September 30, 2014. See Note 7 for further information regarding our repurchase agreements and Note 8 for further discussion of our borrowings.

66


Off-Balance Sheet Arrangements
In the normal course of operations, we engage in a variety of financial transactions that, in accordance with accounting principles generally accepted in the United States of America, are not recorded in our financial statements. These transactions involve, to varying degrees, elements of credit, interest rate and liquidity risk. Such transactions are used primarily to manage customers’ requests for funding and take the form of loan commitments, lines of credit and letters of credit.
The contractual amounts of commitments to extend credit represent the amounts of potential accounting loss should the contract be fully drawn upon, the customer defaults and any existing collateral has no value. We use the same credit policies in making commitments and conditional obligations as we do for on-balance sheet instruments. Financial instruments whose contract amounts represent credit risk at September 30, 2014 and December 31, 2013, are as follows:
 
 
September 30, 2014
 
December 31, 2013
 
 
(In thousands)
Commitments to extend credit(1):
 
 
 
 
Future loan commitments
 
$
1,167,115

 
$
977,262

Standby letters of credit(2)
 
68,155

 
89,232

Total commitments
 
$
1,235,270

 
$
1,066,494

(1)
Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments may require payment of a fee and generally have fixed expiration dates or other termination clauses.
(2)
Standby letters of credit are conditional commitments issued to guarantee the performance of a customer to a third party.
For the three and nine months ended September 30, 2014, we engaged in no off-balance sheet transactions reasonably likely to have a material effect on our financial condition, results of operations or cash flows.
RISK MANAGEMENT
Overview
Managing risk is an essential part of successfully managing a financial institution. Our most prominent risk exposures are credit risk, interest rate risk and market risk. Credit risk is the risk of not collecting the interest and/or the principal balance of a loan or investment when it is due. Interest rate risk is the potential reduction of net interest income as a result of changes in interest rates. Market risk arises from fluctuations in interest rates that may result in changes in the values of financial instruments, such as available for sale securities, which are accounted for on a mark-to-market basis. Other risks that we face are operational risks, liquidity risks and reputation risk. Operational risks include risks related to fraud, regulatory compliance, processing errors, technology and disaster recovery. Liquidity risk is the possible inability to fund obligations to depositors, lenders or borrowers due to unforeseen circumstances. Reputation risk is the risk that negative publicity or press, whether true or not, could cause a decline in our customer base or revenue.
Credit Risk
Analysis of Nonperforming and Classified Assets. We place loans that are 90 days or more past due as to principal or interest payments on nonaccrual status, or prior to that if we have determined based upon current information available to us that the timely collection of principal or interest is not probable. When a loan is placed on nonaccrual status, any previously recorded interest is reversed and recorded as a reduction of loan interest and fee income. Typically, collections of interest and principal received on a nonaccrual loan are applied to the outstanding principal as determined at the time of collection of the loan.
Troubled debt restructurings occur when debtors are granted concessions we would not otherwise consider, because of economic or legal reasons pertaining to the debtor’s financial difficulties. Such concessions would include, but are not limited to, the transfer of assets or the issuance of equity interests by the debtor to satisfy all or part of the debt, modification of the terms of debt or the substitution or addition of debtor(s).

67


The following table provides information with respect to our nonperforming assets and troubled debt restructurings at the dates indicated:
 
 
September 30, 2014
 
December 31, 2013
 
 
(Dollars in thousands)
Nonaccrual loans:
 
 
 
 
Commercial loans:
 
 
 
 
Technology
 
$
10,427

 
$
12,153

Life sciences
 
1,107

 

SBA and USDA
 
264

 
648

Total commercial loans
 
11,798

 
12,801

Real estate loans:
 
 
 
 
SBA and USDA
 

 
1,665

Total real estate loans
 

 
1,665

Total nonaccrual loans
 
11,798

 
14,466

Other real estate owned
 

 

Total nonperforming loans
 
$
11,798

 
$
14,466

Total accruing loans past 90 days or more
 
$

 
$

Foreclosed assets(1)
 

 
119

Nonaccrual troubled debt restructurings
 
3,907

 
3,379

Total troubled debt restructurings
 
3,907

 
3,379

Less nonaccrual troubled debt restructurings included in total nonaccrual loans
 
(3,907
)
 
(3,379
)
Total nonperforming assets and troubled debt restructurings
 
$
11,798

 
$
14,585

Total nonperforming loans to total loans
 
0.93
%
 
1.34
%
Total nonperforming loans to total assets
 
0.39
%
 
0.62
%
Total nonperforming assets and troubled debt restructurings to total assets
 
0.39
%
 
0.63
%
(1)
Foreclosed assets consist of capital stock acquired in lieu of incurring a charge-off.

68


The following tables present the composition of portfolio company nonperforming loans by stage at September 30, 2014 and December 31, 2013 :
 
 
September 30, 2014
 
 
Amount
 
Number
 
Percent
 
 
(Dollars in thousands)
Stage:
 
 
 
 
 
 
Early
 
$
2,343

 
3

 
20.31
%
Expansion
 
6,767

 
4

 
58.67

Late
 
2,425

 
1

 
21.02

Total portfolio company loans
 
$
11,535

 
8

 
100.00
%
 
 
At December 31, 2013
 
 
Amount
 
Number
 
Percent
 
 
(Dollars in thousands)
Stage:
 
 
 
 
 
 
Early
 
$
1,580

 
3

 
13.00
%
Expansion
 
3,287

 
2

 
27.05

Late
 
7,286

 
3

 
59.95

Total portfolio company loans
 
$
12,153

 
8

 
100.00
%
At September 30, 2014, our total nonperforming assets and troubled debt restructurings were $11.8 million, a $2.8 million, or 19.1%, decline from December 31, 2013. At September 30, 2014, nonperforming loans represented 0.93% of our total loans and were comprised of 10 credits that had $8.4 million in specific reserves held against them.
At September 30, 2014, our criticized (performing) and impaired loans represented approximately 9.0% of our total gross loans. This compares to 8.5% at December 31, 2013. 56.6% of our criticized and impaired loans at September 30, 2014 are to companies in the technology sector, across all growth stages. Loans to technology sector companies represented approximately 49.6% of our loan portfolio at September 30, 2014. Loans to early and expansion stage portfolio company clients comprised 77.2% of our nonperforming loans. It is common for an early or expansion stage client’s remaining liquidity to fall temporarily below the threshold necessary for a pass-rated credit during its capital-raising period for a new round of funding. This situation typically lasts only a few weeks and, in our experience, generally resolves itself with a subsequent round of venture funding. As a result, we expect that some of our early-stage and expansion stage clients will be managed through our criticized portfolio during a portion of their life cycle without resulting in net charge-offs.
Management is proactive in its approach to identifying and resolving problem loans and is focused on working with the borrowers and guarantors of these loans to provide loan modifications when warranted. The level of nonperforming assets fluctuates in response to changing economic and market conditions, the relative size and composition of the loan portfolio, as well as management’s degree of success in resolving problem assets.
Interest income that would have been recorded had nonaccruing loans and troubled debt restructurings been current in accordance with their original terms and had been outstanding throughout the period, amounted to $0.2 million and $0.5 million, respectively, for the three and nine months ended September 30, 2014, and $0.2 million and $0.6 million, respectively, for the three and nine months ended September 30, 2013.
Allowance for Loan Losses. The allowance for loan losses, a material estimate which could change significantly in the near-term, is established through a provision for loan losses charged to earnings to account for losses that are inherent in the loan portfolio and estimated to occur, and is maintained at a level that management believes is adequate to absorb losses in the loan portfolio. Loan losses are charged against the allowance for loan losses when management believes that the uncollectibility of the principal loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance for loan losses when received.
Management’s judgment in determining the adequacy of the allowance is inherently subjective, as it requires estimates that are susceptible to significant revision as more information becomes available and as situations change.

69


The allowance for loan losses is evaluated on a monthly basis by management and takes into consideration such factors as changes in the nature and volume of the loan portfolio, overall portfolio quality, review of specific problem loans and current economic conditions and trends that may affect the borrower’s ability to repay.
The allowance for loan losses consists of the following key elements:
Specific allowance for identified impaired loans. For such loans that are identified as impaired, an allowance is established when the discounted cash flows (or collateral value if the loan is collateral dependent) or observable market price of the impaired loan are lower than the carrying value of that loan.
General valuation allowance, which represents a valuation allowance on the remainder of the loan portfolio, after excluding impaired loans. For this portion of the allowance, loans are reviewed based on industry, stage and structure, and are assigned allowance percentages based on historical loan loss experience adjusted for qualitative factors. Qualitative factors that, in management’s judgment, affect the collectibility of the portfolio as of the evaluation date, may include changes in lending policies and procedures; changes in national and local economic and business conditions, including the condition of various market segments; changes in the nature and volume of the portfolio; changes in the experience, ability and depth of lending management and staff; changes in the volume and severity of past due and classified loans and in the volume of nonaccruals, trouble debt restructurings, and other loan modifications; the existence and effect of any concentrations of credit and changes in the level of such concentrations; and the effect of external factors, such as competition and legal and regulatory requirements, on the level of estimated and inherent credit losses in the Bank’s current portfolio.
The following table sets forth the breakdown of the allowance for loan losses by loan category at the dates indicated:
 
 
September 30, 2014
 
December 31, 2013
 
 
Amount
 
% of Allowance of
Total
Allowance
 
% of
Loans in
Category
to Total
Loans
 
Amount
 
% of Allowance of
Total
Allowance
 
% of
Loans in
Category
to Total
Loans
 
 
(Dollars in thousands)
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Technology
 
$
16,196

 
70.98
%
 
49.65
%
 
$
12,476

 
67.88
%
 
50.02
%
Life sciences
 
3,009

 
13.19

 
18.80

 
1,894

 
10.31

 
20.61

Asset-based loans
 
1,864

 
8.17

 
11.91

 
1,894

 
10.31

 
10.24

Venture capital/private equity
 
214

 
0.94

 
12.46

 
197

 
1.07

 
13.20

SBA and USDA
 
585

 
2.56

 
2.60

 
627

 
3.41

 
2.18

Other
 
8

 
0.04

 
0.42

 
2

 
0.01

 
0.13

Total commercial loans
 
21,876

 
95.88

 
95.84

 
17,090

 
92.99

 
96.38

Real estate loans:
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
724

 
3.17

 
2.47

 
1,163

 
6.33

 
2.53

Total real estate loans
 
724

 
3.17

 
2.47

 
1,163

 
6.33

 
2.53

Construction:
 
 
 
 
 
 
 
 
 
 
 
 
SBA and USDA
 
23

 
0.10

 
0.18

 
10

 
0.05

 
0.03

Total construction loans
 
23

 
0.10

 
0.18

 
10

 
0.05

 
0.03

Credit cards
 
193

 
0.85

 
1.51

 
116

 
0.63

 
1.06

Total
 
$
22,816

 
100.00
%
 
100.00
%
 
$
18,379

 
100.00
%
 
100.00
%

70


Analysis of Loan Loss Experience. The following table sets forth an analysis of the allowance for loan losses for the periods indicated:
 
 
Three Months Ended September 30,
 
 
2014
 
2013
 
 
(Dollars in thousands)
Allowance at beginning of period
 
$
21,556

 
$
18,217

Provision for loan losses
 
2,500

 
2,850

Charge-offs:
 
 
 
 
Commercial loans:
 
 
 
 
Technology
 
382

 
2,988

Life sciences
 
1,107

 

SBA and USDA
 

 

Total commercial loans
 
1,489

 
2,988

Credit cards
 

 

Total charge offs
 
1,489

 
2,988

Recoveries:
 
 
 
 
Commercial loans:
 
 
 
 
Technology
 
(13
)
 
(14
)
Life sciences
 
(5
)
 

SBA and USDA
 
(14
)
 

Total commercial loans
 
(32
)
 
(14
)
Real estate loans:
 
 
 
 
SBA and USDA
 
(217
)
 

Total real estate loans
 
(217
)
 

Credit cards
 

 

Total recoveries
 
(249
)
 
(14
)
Net charge offs
 
1,240

 
2,974

Allowance at end of period
 
$
22,816

 
$
18,093

Allowance for loan losses to total loans at end of period
 
1.79
%
 
1.78
%
Net charge offs to average loans outstanding during period (annualized)
 
0.40
%
 
1.25
%


71


 
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
 
(Dollars in thousands)
Allowance at beginning of period
 
$
18,379

 
$
13,843

Provision for loan losses
 
8,614

 
9,340

Charge-offs:
 
 
 
 
Commercial loans:
 
 
 
 
Technology
 
2,548

 
5,932

Life sciences
 
1,516

 

SBA and USDA
 
518

 

Total commercial loans
 
4,582

 
5,932

Credit cards
 

 

Total charge offs
 
4,582

 
5,932

Recoveries:
 
 
 
 
Commercial loans:
 
 
 
 
Technology
 
(169
)
 
(692
)
Life sciences
 
(5
)
 

SBA and USDA
 
(14
)
 
(150
)
Total commercial loans
 
(188
)
 
(842
)
Real estate loans:
 
 
 
 
SBA and USDA
 
(217
)
 

Total real estate loans
 
(217
)
 

Credit cards
 

 

Total recoveries
 
(405
)
 
(842
)
Net charge offs
 
4,177

 
5,090

Allowance at end of period
 
$
22,816

 
$
18,093

Allowance for loan losses to total loans at end of period
 
1.79
%
 
1.78
%
Net charge offs to average loans outstanding during period (annualized)
 
0.49
%
 
0.78
%
Interest Rate Risk
Interest Rate Risk Management. Market risk is defined as the risk of adverse fluctuations in the market value of financial instruments due to changes in market interest rates. Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our rate-sensitive assets and liabilities, widening or tightening of credit spreads, changes in the general level of market interest rates and changes in the shape and level of market yield curves. Additionally, changes in interest rates can influence the rate of principal prepayments on mortgage securities, which affects the rate of amortization of purchase premiums and discounts, and ultimately the yield, of such securities. Other market risks include foreign currency exchange risk and equity price risk. These risks are not considered significant and no separate quantitative information concerning them is presented herein.
We manage the interest rate sensitivity of our interest-bearing liabilities and interest-earning assets in an effort to minimize the adverse effects of changes in the interest rate environment. Management of interest rate risk is carried out primarily through strategies involving our available-for-sale securities and available funding sources. In addition, our policies permit the use of on- and off-balance sheet derivative financial instruments to assist in managing interest rate risk, although to date we have not entered into any derivative financial instruments for such purposes.
We have a Management Asset/Liability Committee to communicate, coordinate and control all aspects involving interest rate risk management. The Management Asset/Liability Committee, with oversight from the Board Asset/Liability Committee (“BALCO”), establishes and monitors the volume, maturities, pricing and mix of assets and funding sources with the objective of managing assets and funding sources to provide results that are consistent with liquidity, growth, risk limits and profitability goals. Adherence to relevant policies is monitored on an ongoing basis.

72


Market Risk
Net Interest Income Simulation Analysis. The matching of assets and liabilities may be analyzed by examining the extent to which such assets and liabilities are “interest sensitive.” An asset or liability is said to be interest rate sensitive within a specific time period if it will mature or reprice within that time period. We analyze our interest rate sensitivity position to manage the risk associated with interest rate movements through the use of a net interest income (“NII”) simulation model.
The NII simulation is completed monthly and presented to the Asset/Liability Management Committee. The simulation provides an estimate of the impact of changes in interest rates on net interest income under a range of assumptions. The numerous assumptions used in the simulation process are reviewed by the Asset/Liability Management Committee on a monthly basis. Changes to these assumptions can significantly affect the results of the simulation. The simulation incorporates assumptions regarding the potential timing in the repricing of certain assets and liabilities when market rates change and the changes in spreads between different market rates. The simulation analysis incorporates management’s current assessment of the risk that pricing margins will change adversely over time due to competition or other factors.
Simulation analysis is only an estimate of our interest rate risk exposure at a particular point in time. We continually review the potential effect changes in interest rates could have on the repayment of rate sensitive assets and funding requirements of rate sensitive liabilities.
The table below sets forth an approximation of our NII sensitivity exposure for the 12-month periods beginning September 30, 2014. The simulation uses projected repricing of assets and liabilities beginning September 30, 2014, on the basis of contractual maturities, anticipated repayments and scheduled rate adjustments. Prepayment rates can have a significant impact on interest income simulation. Because of the large percentage of variable rate loans and mortgage-backed securities we hold, rising or falling interest rates have a significant impact on the prepayment speeds of our earning assets that in turn affect the rate sensitivity position. Generally, when interest rates rise, prepayments tend to slow. When interest rates fall, mortgage prepayments tend to rise. Our asset sensitivity would be reduced if mortgage prepayments slow and vice versa. While we believe such assumptions to be reasonable, there can be no assurance that assumed prepayment rates will approximate actual future mortgage-backed security and loan repayment activity.
Numerous assumptions are used to model deposits since they do not have a contractual maturity and rates are internally set based on market conditions and management goals. Our assumption is that the rate paid on interest-bearing deposits is tied to the fed funds rate. We also use a pricing beta that represents the correlation between the fed funds rate and the actual rate modeled on interest-bearing deposits. We currently model interest-bearing deposits using a pricing beta of approximately 70% such that for an assumed 1.00% move in the fed funds rate there would be a 0.70% change in the modeled rate that we would pay on interest-bearing deposits. In addition, we also make assumptions as to how deposits will shift between interest-bearing products and non-interest bearing products in response to changes in rates. As rates increase we assume that an increasing percentage of deposits will shift from non-interest bearing to interest-bearing resulting in higher rates being paid on larger balances. The opposite would be true when rates are assumed to decrease.
 
 
Estimated Increase/Decrease
in Net Interest Income
Basis Point (“bp”) Change in
Interest Rates
 
12 Months Beginning
September 30, 2014
300
 
11.8%
200
 
9.7
100
 
6.0
(100)
 
(4.1)
(200)
 
(6.0)
Rates are immediately increased at the beginning of the projection. The results show that we are asset sensitive and that net interest income will increase as rates rise and will decrease as rates decline. Interest rates do not normally move instantaneously, but the analysis is useful to understanding the potential direction and magnitude of net interest income changes due to changing interest rates.
Liquidity Risk
Liquidity Management. Liquidity management is the ability to meet current and future financial obligations of a short-term nature. Our primary sources of funds consist of deposit inflows, loan repayments and sales, maturities and sales of securities. While maturities and scheduled amortization of loans and securities are predictable sources of funds, deposit flows,

73


mortgage prepayments and loan and security sales are greatly influenced by general interest rates, economic conditions and competition.
We regularly adjust our investment in liquid assets based upon our assessment of (1) expected loan demand, (2) expected deposit flows, (3) yields available on interest-earning deposits and securities, and (4) the objectives of our asset/liability management, funds management and liquidity policies. The objective of the liquidity policy is to reduce the risk to our earnings and capital arising from the inability to meet obligations in a timely manner without incurring unacceptable losses. This entails ensuring sufficient funds are available at a reasonable cost to meet potential demands from both fund providers and borrowers. Liquid assets, defined as cash, due from banks, federal funds sold, repurchase agreements, and available-for-sale securities, were 45.5% of total assets at September 30, 2014. Excess liquid assets are generally invested in investment grade available-for-sale securities.
Our most liquid assets are cash and cash equivalents. The levels of these assets depend on our operating, financing, lending and investing activities during any given period. At September 30, 2014, cash and cash equivalents totaled $185.6 million. Securities classified as available-for-sale, which provide additional sources of liquidity, totaled $1.2 billion at September 30, 2014. In addition, at September 30, 2014, we had the ability to borrow $199.0 million from the FHLB. There were no outstanding borrowings under this line at September 30, 2014. Additionally, at September 30, 2014, we had the ability to access $84.4 million from the Federal Reserve Bank’s Discount Window on a collateralized basis. There were no outstanding borrowings under this line at September 30, 2014. We also maintain $60.0 million of unsecured lines of credit from four financial institutions to access federal funds. We had not accessed these unsecured lines of credit as of September 30, 2014. We believe that our liquid assets combined with the available credit lines provide adequate liquidity to meet our current financial obligations.
The following table presents our contractual obligations at September 30, 2014:
 
 
Payments Due by Period
 
 
Total
 
Less Than
One Year
 
One to
Three
Years
 
Three to
Five
Years
 
More
Than Five
Years
 
 
(In thousands)
Contractual Obligations
 
 
 
 
 
 
 
 
 
 
Deposits without stated maturity
 
$
2,651,938

 
$
2,651,938

 
$

 
$

 
$

Time deposits
 
16,507

 
15,507

 
1,000

 

 

FHLB and other borrowings
 

 

 

 

 

Junior subordinated debentures
 

 

 

 

 

Operating lease obligations
 
12,797

 
2,687

 
4,442

 
1,998

 
3,670

Total
 
$
2,681,242

 
$
2,670,132

 
$
5,442

 
$
1,998

 
$
3,670

Capital Management. Our management seeks to maintain adequate capital to support anticipated asset growth, operating needs and unexpected risks, and to ensure that Square 1 Financial and Square 1 Bank are in compliance with all current and anticipated regulatory capital guidelines. Our primary sources of new capital include retained earnings and proceeds from the sale and issuance of capital stock or other securities. Our management engages, in consultation with the BALCO, in an annual capital planning process in an effort to optimize the use of the capital available to us and to appropriately plan for our future capital needs. The capital plan, approved annually by the Board of Directors, considers capital needs for the foreseeable future and allocates capital to both existing and future business activities. Expected future use or activities for which capital may be set aside include balance sheet growth and associated relative increases in market or credit exposure, investment activity, potential product and business expansions, acquisitions and strategic or infrastructure investments.
Regulatory capital ratios for Square 1 Financial and the Bank exceeded minimum federal regulatory guidelines for a well-capitalized depository institution as of September 30, 2014 and December 31, 2013. See Note 11 to the consolidated financial statements for further information. On January 1, 2015, the Basel III regulatory standard on bank capital adequacy will become effective and will have an impact on capital ratios.

74


Capital ratios for Square 1 Financial and Square 1 Bank, compared to the minimum regulatory ratios to be considered “well capitalized” and “adequately capitalized,” are set forth below.
 
 
 
September 30,
2014
 
December 31, 2013
 
Minimum
Ratio to be
“Well
Capitalized”
 
Minimum
Ratio to be
“Adequately
Capitalized”
 
 
Square 1 Financial:
 
 
 
 
 
 
 
 
 
Total risk-based capital ratio
 
14.84
%
 
12.46
%
 
10.00
%
 
8.00
%
 
Tier 1 risk-based capital ratio
 
13.69

 
11.38

 
6.00

 
4.00

 
Tier 1 leverage ratio
 
10.05

 
8.34

 
N/A

 
4.00

 
Tangible common equity to tangible assets ratio
 
9.83

 
7.89

 
N/A

 
N/A

 
Tangible equity to risk-weighted assets ratio
 
14.10

 
10.52

 
N/A

 
N/A

 
 
 
 
 
 
 
 
 
 
 
Square 1 Bank:
 
 
 
 
 
 
 
 
 
Total risk-based capital ratio
 
14.54
%
 
12.21
%
 
10.00
%
 
8.00
%
 
Tier 1 risk-based capital ratio
 
13.40

 
11.13

 
6.00

 
4.00

 
Tier 1 leverage ratio
 
9.83

 
8.16

 
5.00

 
4.00

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See "Management's Discussion and Analysis of Financial Condition and Results of Operations - Risk Management" for discussion of quantitative and qualitative disclosures about market risk.
ITEM 4. CONTROLS AND PROCEDURES
As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective, in all material respects, as of the end of the period covered by this report, in ensuring that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to management, including the Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. There were no changes in our internal control over financial reporting identified in management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the last fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are party to other legal actions that are routine and incidental to our business. In management’s opinion, the outcome of these matters, individually or in the aggregate, will not have a material effect on our results of operations or financial position.
See also Note 16 "Off-balance Sheet Risk, Commitments and Contingencies" of the "Notes to Interim Consolidated Financial Statements (Unaudited)" under Part I, Item 1 of this Form 10-Q.
ITEM 1A. RISK FACTORS
There have been no material changes in our assessment of our risk factors from those set forth in the Registration Statement.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On March 26, 2014 our registration statement on Form S-1 (File No. 333-193197) was declared effective by the Securities and Exchange Commission (SEC) for our initial public offering pursuant to which we sold an aggregate of 3,593,750 shares of our Class A common stock at a price of $18.00 per share.

75


As a result of the offering, we received net proceeds of approximately $59.0 million, after deducting approximately $3.8 million in underwriting discounts and commissions and approximately $1.4 million in IPO-related expenses.
There has been no material change in the planned use of proceeds from our initial public offering as described in our final prospectus filed with the SEC on March 27, 2014 pursuant to Rule 424(b).
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 5. OTHER INFORMATION
None.

76


ITEM 6. EXHIBITS
List of Exhibits
 
 
 
 
 
Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
3.1

 
Second Amended and Restated Certificate of Incorporation of Square 1 Financial, Inc.
 
(incorporated by reference to the Exhibit 3.1 in the Registrant’s Quarterly Report on Form 10-Q for the period ended June 30, 2014, File No. 001-36372)
 
 
 
 
 
3.2

 
Bylaws of Square 1 Financial, Inc.
 
(incorporated by reference to the Exhibit 3.2 in the Registrant’s Registration Statement on Form S-1, File No. 333-193197)
 
 
 
 
 
4.1

 
Specimen Stock Certificate for Class A Common Stock of Square 1 Financial, Inc.
 
(incorporated by reference to the Exhibit 4.1 in the Registrant’s Registration Statement on Form S-1, File No. 333-193197)
 
 
 
 
 
10.1

 
Square 1 Financial, Inc. 2009 Stock Incentive Plan, as amended
 
(incorporated by reference to the Exhibit 99.1 in the Registrant’s Registration Statement on Form S-8, File No. 333-195221)
 
 
 
 
 
31.1

 
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
Filed herewith
 
 
 
 
 
31.2

 
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
Filed herewith
 
 
 
 
 
32.1

 
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
Filed herewith
 
 
 
 
 
32.2

 
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
Filed herewith
 
 
 
 
 
101.INS

 
XBRL Instance Document
 
Filed herewith
 
 
 
 
 
101.SCH

 
XBRL Taxonomy Extension Schema Document
 
Filed herewith
 
 
 
 
 
101.CAL

 
XBRL Taxonomy Calculation Linkbase Document
 
Filed herewith
 
 
 
 
 
101.LAB

 
XBRL Taxonomy Label Linkbase Document
 
Filed herewith
 
 
 
 
 
101.PRE

 
XBRL Taxonomy Presentation Linkbase Document
 
Filed herewith
 
 
 
 
 
101.DEF

 
XBRL Taxonomy Definition Linkbase Document
 
Filed herewith
 
 
 
 
 

77


SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Durham, State of North Carolina on November 10, 2014.
 
 
 
 
 
Square 1 Financial, Inc.
 
 
 
 
By:
/s/ Douglas H. Bowers
 
 
Douglas H. Bowers
President and Chief Executive Officer
 
 
 
 
 
/s/ Patrick Oakes
 
 
Patrick Oakes
Executive Vice President and Chief Financial Officer (principal financial and accounting officer)
 
 
 

 


78